Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Wolfgang Oertel

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Rats

Anatomy

Procedures

Geographic Areas

Germany

Concepts & Ideas

Drug Dose-Response Relationship

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Höllerhage Matthias; Matusch Andreas; Champy Pierre; Lombès Anne; Ruberg Merle; Oertel Wolfgang H; Höglinger Günter U
Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies.
Larisch Astrid; Oertel Wolfgang H; Eggert Karla
Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson's disease. A National Survey of German neurologists in private practice.
Jauss M; Oertel W; Allendoerfer J; Misselwitz B; Hamer H
Bias in request for medical care and impact on outcome during office and non-office hours in stroke patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Wolfgang Oertel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Höllerhage Matthias; Matusch Andreas; Champy Pierre; Lombès Anne; Ruberg Merle; Oertel Wolfgang H; Höglinger Günter U
Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies.
Experimental neurology 2009;220(1):133-42.
2009: Larisch Astrid; Oertel Wolfgang H; Eggert Karla
Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson's disease. A National Survey of German neurologists in private practice.
Journal of neurology 2009;256(10):1681-8.
2009: Jauss M; Oertel W; Allendoerfer J; Misselwitz B; Hamer H
Bias in request for medical care and impact on outcome during office and non-office hours in stroke patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(10):1165-7.
2009: Bauer Sebastian; Cepok Sabine; Todorova-Rudolph Anelia; Nowak Mareike; Köller Martina; Lorenz Rüdiger; Oertel Wolfgang H; Rosenow Felix; Hemmer Bernhard; Hamer Hajo M
Etiology and site of temporal lobe epilepsy influence postictal cytokine release.
Epilepsy research 2009;86(1):82-8.
2009: Stamelou Maria; Matusch Andreas; Elmenhorst David; Hurlemann René; Eggert Karla M; Zilles Karl; Oertel Wolfgang H; Höglinger Günter U; Bauer Andreas
Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1170-5.
2009: Bach Jan-Philipp; Oertel Wolfgang H; Dodel Richard; Jessen Frank
Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1241-2.
2009: Unger Marcus M; Möller Jens C; Ohletz Tim; Stiasny-Kolster Karin; Oertel Wolfgang H; Mayer Geert
Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder.
Journal of neurology 2009;256(6):874-7.
2009: Winter Yaroslav; Wolfram Caroline; Schaeg Matthias; Reese Jens-Peter; Oertel Wolfgang H; Dodel Richard; Back Tobias
Evaluation of costs and outcome in cardioembolic stroke or TIA.
Journal of neurology 2009;256(6):954-63.
2009: Scholz Sonja W; Houlden Henry; Schulte Claudia; Sharma Manu; Li Abi; Berg Daniela; Melchers Anna; Paudel Reema; Gibbs J Raphael; Simon-Sanchez Javier; Paisan-Ruiz Coro; Bras Jose; Ding Jinhui; Chen Honglei; Traynor Bryan J; Arepalli Sampath; Zonozi Ryan R; Revesz Tamas; Holton Janice; Wood Nick; Lees Andrew; Oertel Wolfgang; Wüllner Ullrich; Goldwurm Stefano; Pellecchia Maria Teresa; Illig Thomas; Riess Olaf; Fernandez Hubert H; Rodriguez Ramon L; Okun Michael S; Poewe Werner; Wenning Gregor K; Hardy John A; Singleton Andrew B; Gasser Thomas
SNCA variants are associated with increased risk for multiple system atrophy.
Annals of neurology 2009;65(5):610-4.
2009: Ehret R; Balzer-Geldsetzer M; Reese J P; Dodel I; Becker E; Christopher A; Friedrich H; Kraemer S; Lüer W; Müngersdorf M; Puzich R; Rohr A; Schultes-Platzek I; Siefjediers V; Tiel-Wilck K; Oertel W H; Dodel R
[Direct costs for Parkinson's treatment in private neurology practices in Berlin]
Der Nervenarzt 2009;80(4):452-8.
2009: Stamelou Maria; Pilatus Ulrich; Reuss Alexander; Magerkurth Jörg; Eggert Karla M; Knake Susanne; Ruberg Merle; Schade-Brittinger Carmen; Oertel Wolfgang H; Höglinger Günter U
In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(4):861-70.
2009: Giladi Nir; Tal Joseph; Azulay Tali; Rascol Oliver; Brooks David J; Melamed Eldad; Oertel Wolfgang; Poewe Werner H; Stocchi Fabrizio; Tolosa Eduardo
Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):655-61.
2009: Ludolph A C; Kassubek J; Landwehrmeyer B G; Mandelkow E; Mandelkow E-M; Burn D J; Caparros-Lefebvre D; Frey K A; de Yebenes J G; Gasser T; Heutink P; Höglinger G; Jamrozik Z; Jellinger K A; Kazantsev A; Kretzschmar H; Lang A E; Litvan I; Lucas J J; McGeer P L; Melquist S; Oertel W; Otto M; Paviour D; Reum T; Saint-Raymond A; Steele J C; Tolnay M; Tumani H; van Swieten J C; Vanier M T; Vonsattel J-P; Wagner S; Wszolek Z K;
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(3):297-309.
2009: Tackenberg Björn; Jelcic Ilijas; Baerenwaldt Anne; Oertel Wolfgang H; Sommer Norbert; Nimmerjahn Falk; Lünemann Jan D
Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(12):4788-92.
2009: Marshall Vicky L; Reininger Cornelia B; Marquardt Moritz; Patterson Jim; Hadley Donald M; Oertel Wolfgang H; Benamer Hani T S; Kemp Paul; Burn David; Tolosa Eduardo; Kulisevsky Jamie; Cunha Luis; Costa Durval; Booij Jan; Tatsch Klaus; Chaudhuri K Ray; Ulm Gudrun; Pogarell Oliver; Höffken Helmut; Gerstner Anja; Grosset Donald G
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
Movement disorders : official journal of the Movement Disorder Society 2009;24(4):500-8.
2009: Möller Jens Carsten; Unger Miriam; Stiasny-Kolster Karin; Kaussner Yvonne; Penzel Thomas; Oertel Wolfgang Hermann; Hemmeter Ulrich
Continuous sleep EEG monitoring in PD patients with and without sleep attacks.
Parkinsonism & related disorders 2009;15(3):238-41.
2009: Teepker Michael; Munk Karoline; Mylius Veit; Haag Anja; Möller Jens C; Oertel Wolfgang H; Schepelmann Karsten
Serum concentrations of s100b and NSE in migraine.
Headache 2009;49(2):245-52.
2009: Bacher Michael; Depboylu Candan; Du Yansheng; Noelker Carmen; Oertel Wolfgang H; Behr Thomas; Henriksen Gjermund; Behe Martin; Dodel Richard
Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
Neuroscience letters 2009;449(3):240-5.
2009: Mylius V; Engau I; Teepker M; Stiasny-Kolster K; Schepelmann K; Oertel W H; Lautenbacher S; Möller J C
Pain sensitivity and descending inhibition of pain in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2009;80(1):24-8.
2009: von Campenhausen Sonja; Winter Yaroslav; Gasser Julia; Seppi Klaus; Reese Jens-P; Pfeiffer Karl-P; Geiger-Gritsch Sabine; Bötzel Kai; Siebert Uwe; Oertel Wolfgang H; Dodel Richard; Poewe Werner
[Cost of illness and health service patterns in Morbus Parkinson in Austria.]
Wiener klinische Wochenschrift 2009;121(17-18):574-82.
2009: Winter Yaroslav; von Campenhausen Sonja; Popov Georgy; Reese Jens P; Klotsche Jens; Bötzel Kai; Gusev Eugene; Oertel Wolfgang H; Dodel Richard; Guekht Alla
Costs of illness in a Russian cohort of patients with Parkinson's disease.
PharmacoEconomics 2009;27(7):571-84.
2009: Rissling Ida; Strauch Konstantin; Höft Christine; Oertel Wolfgang Hermann; Möller Jens Carsten
Haplotype analysis of the engrailed-2 gene in young-onset Parkinson's disease.
Neuro-degenerative diseases 2009;6(3):102-5.
2009: Eggert Karla; Larisch Astrid; Dodel Richard; Bormann Cornelia; Oertel Wolfgang H
Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologists.
European neurology 2009;61(4):216-22.
2008: Trenkwalder Claudia; Hening Wayne A; Montagna Pasquale; Oertel Wolfgang H; Allen Richard P; Walters Arthur S; Costa Joao; Stiasny-Kolster Karin; Sampaio Cristina
Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.
Movement disorders : official journal of the Movement Disorder Society 2008;23(16):2267-302.
2008: Oertel Wolfgang H; Benes Heike; Garcia-Borreguero Diego; Geisler Peter; Högl Birgit; Trenkwalder Claudia; Tacken Ingrid; Schollmayer Erwin; Kohnen Ralf; Stiasny-Kolster Karin;
One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome.
Sleep medicine 2008;9(8):865-73.
2008: Althaus Astrid; Becker Oliver Arránz; Spottke Annika; Dengler Reinhard; Schneider Frank; Kloss Manja; Eggert Karla; Oertel Wolfgang H; Dillmann Ulrich; Herting Birgit; Classen Joseph; Dodel Richard
Frequency and treatment of depressive symptoms in a Parkinson's disease registry.
Parkinsonism & related disorders 2008;14(8):626-32.
2008: Strzelczyk A; Möller J C; Stamelou M; Matusch A; Oertel W H
[Atypical Parkinson syndromes]
Der Nervenarzt 2008;79(10):1203-20; quiz 1221-2.
2008: Dorst J; Haag A; Knake S; Oertel W H; Hamer H M; Rosenow F
Functional transcranial Doppler sonography and a spatial orientation paradigm identify the non-dominant hemisphere.
Brain and cognition 2008;68(1):53-8.
2008: Möller J C; Eggert K M; Unger M; Odin P; Chaudhuri K R; Oertel W H
Clinical risk-benefit assessment of dopamine agonists.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15 Suppl 2():15-23.
2008: Schormair Barbara; Kemlink David; Roeske Darina; Eckstein Gertrud; Xiong Lan; Lichtner Peter; Ripke Stephan; Trenkwalder Claudia; Zimprich Alexander; Stiasny-Kolster Karin; Oertel Wolfgang; Bachmann Cornelius G; Paulus Walter; Högl Birgit; Frauscher Birgit; Gschliesser Viola; Poewe Werner; Peglau Ines; Vodicka Pavel; Vávrová Jana; Sonka Karel; Nevsimalova Sona; Montplaisir Jacques; Turecki Gustavo; Rouleau Guy; Gieger Christian; Illig Thomas; Wichmann H-Erich; Holsboer Florian; Müller-Myhsok Bertram; Meitinger Thomas; Winkelmann Juliane
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome.
Nature genetics 2008;40(8):946-8.
2008: Herzog Jan; Pogarell Oliver; Pinsker Marcus O; Kupsch Andreas; Oertel Wolfgang H; Lindvall Olle; Deuschl Günther; Volkmann Jens
Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.
Movement disorders : official journal of the Movement Disorder Society 2008;23(9):1293-6.
2008: Trenkwalder Claudia; Benes Heike; Poewe Werner; Oertel Wolfgang H; Garcia-Borreguero Diego; de Weerd Al W; Ferini-Strambi Luigi; Montagna Pasquale; Odin Per; Stiasny-Kolster Karin; Högl Birgit; Chaudhuri K Ray; Partinen Markku; Schollmayer Erwin; Kohnen Ralf;
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
Lancet neurology 2008;7(7):595-604.
2008: Möller J C; Rissling I; Mylius V; Höft C; Eggert K M; Oertel W H
The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(7):743-5.
2008: Möller J C; Tackenberg B; Heinzel-Gutenbrunner M; Burmester R; Oertel W H; Bandmann O; Müller-Vahl K R
Immunophenotyping in Tourette syndrome--a pilot study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(7):749-53.
2008: Hattemer Katja; Knake Susanne; Oertel Wolfgang H; Hamer Hajo M; Rosenow Felix
Recurrent alcohol-induced seizures in a patient with chronic alcohol abuse.
Epileptic disorders : international epilepsy journal with videotape 2008;10(2):162-4.
2008: Köllensperger Martin; Geser Felix; Seppi Klaus; Stampfer-Kountchev Michaela; Sawires Martin; Scherfler Christoph; Boesch Sylvia; Mueller Joerg; Koukouni Vasiliki; Quinn Niall; Pellecchia Maria Teresa; Barone Paolo; Schimke Nicole; Dodel Richard; Oertel Wolfgang; Dupont Erik; Østergaard Karen; Daniels Christine; Deuschl Günther; Gurevich Tanya; Giladi Nir; Coelho Miguel; Sampaio Cristina; Nilsson Christer; Widner Håkan; Sorbo Francesca Del; Albanese Alberto; Cardozo Adriana; Tolosa Eduardo; Abele Michael; Klockgether Thomas; Kamm Christoph; Gasser Thomas; Djaldetti Ruth; Colosimo Carlo; Meco Giuseppe; Schrag Anette; Poewe Werner; Wenning Gregor K;
Red flags for multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2008;23(8):1093-9.
2008: Bauer Sebastian; Köller Martina; Cepok Sabine; Todorova-Rudolph Anelia; Nowak Mareike; Nockher Wolfgang A; Lorenz Rüdiger; Tackenberg Björn; Oertel Wolfgang H; Rosenow Felix; Hemmer Bernhard; Hamer Hajo M
NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy.
Experimental neurology 2008;211(2):370-7.
2008: Tackenberg B; Gellert K; Kruth J; Oertel W H; Sommer N
[Myasthenia gravis--diagnosis, therapy and special problems]
MMW Fortschritte der Medizin 2008;150 Suppl 2():68, 70-2.
2008: Eggert Karla; Schrader Christoph; Hahn Michaela; Stamelou Maria; Rüssmann Anne; Dengler Reinhard; Oertel Wolfgang; Odin Per
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications.
Clinical neuropharmacology 2008;31(3):151-66.
2008: Stamelou Maria; Reuss Alexander; Pilatus Ulrich; Magerkurth Jörg; Niklowitz Petra; Eggert Karla M; Krisp Andrea; Menke Thomas; Schade-Brittinger Carmen; Oertel Wolfgang H; Höglinger Günter U
Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):942-9.
2008: Kemlink David; Plazzi Giuseppe; Vetrugno Roberto; Provini Federica; Polo Olli; Stiasny-Kolster Karin; Oertel Wolfgang; Nevsimalova Sona; Sonka Karel; Högl Birgit; Frauscher Birgit; Hadjigeorgiou Georgios M; Pramstaller Peter P; Lichtner Peter; Meitinger Thomas; Müller-Myshok Bertram; Winkelmann Juliane; Montagna Pasquale
Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13.
Neurogenetics 2008;9(2):75-82.
2008: Klein K M; Theisen F; Knake S; Oertel W H; Hebebrand J; Rosenow F; Hamer H M
Topiramate, nutrition and weight change: a prospective study.
Journal of neurology, neurosurgery, and psychiatry 2008;79(5):590-3.
2008: Knake S; Gruener J; Hattemer K; Klein K M; Bauer S; Oertel W H; Hamer H M; Rosenow F
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
Journal of neurology, neurosurgery, and psychiatry 2008;79(5):588-9.
2008: Bach Jan-Philipp; Sommer Norbert; Möller Jens Carsten; Oertel Wolfgang H; Dodel Richard; Gasser Thomas
Parkinson's syndrome in a young patient with Klinefelter's syndrome--a case report.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):771-2.
2008: Strzelczyk Adam; Bauer Sebastian; Knake Susanne; Oertel Wolfgang H; Hamer Hajo M; Rosenow Felix
Ictal asystole in temporal lobe epilepsy before and after pacemaker implantation.
Epileptic disorders : international epilepsy journal with videotape 2008;10(1):39-44.
2008: Klein Karl Martin; Preisig-Müller Regina; Knake Susanne; Hamer Hajo M; Oertel Wolfgang H; Neubauer Bernd A; Daut Jürgen; Rosenow Felix
Evaluation of susceptibility loci in an extended pedigree with idiopathic generalized epilepsy.
Epileptic disorders : international epilepsy journal with videotape 2008;10(1):13-8.
2008: Möller J Carsten; Oertel Wolfgang H
Single-question screen for restless legs syndrome.
Nature clinical practice. Neurology 2008;4(3):132-3.
2008: Unger Marcus M; Möller Jens C; Stiasny-Kolster Karin; Mankel Katharina; Berg Daniela; Walter Uwe; Hoeffken Helmut; Mayer Geert; Oertel Wolfgang H
Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):596-9.
2008: Alvarez-Fischer Daniel; Henze Carmen; Strenzke Corinna; Westrich Jan; Ferger Boris; Höglinger Günter U; Oertel Wolfgang H; Hartmann Andreas
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Experimental neurology 2008;210(1):182-93.
2008: Oertel Wolfgang H; Benes Heike; Garcia-Borreguero Diego; Geisler Peter; Högl Birgit; Saletu Bernd; Trenkwalder Claudia; Sommerville Kenneth W; Schollmayer Erwin; Kohnen Ralf; Stiasny-Kolster Karin;
Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe.
Sleep medicine 2008;9(3):228-39.
2008: Mayer Geert; Kesper Karl; Ploch Thomas; Canisius Sebastian; Penzel Thomas; Oertel Wolfgang; Stiasny-Kolster Karin
Quantification of tonic and phasic muscle activity in REM sleep behavior disorder.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2008;25(1):48-55.
2008: Riedel Oliver; Klotsche Jens; Spottke Annika; Deuschl Günther; Förstl Hans; Henn Fritz; Heuser Isabella; Oertel Wolfgang; Reichmann Heinz; Riederer Peter; Trenkwalder Claudia; Dodel Richard; Wittchen Hans-Ulrich
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
Journal of neurology 2008;255(2):255-64.
2008: Leinweber Barbara; Möller J Carsten; Scherag Andre; Reuner Ulrike; Günther Peter; Lang Christoph J G; Schmidt Hartmut H J; Schrader Christoph; Bandmann Oliver; Czlonkowska Anna; Oertel Wolfgang H; Hefter Harald
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(1):54-62.
2008: Eggert Karla M; Reese Jens P; Oertel Wolfgang H; Dodel Richard
Cost effectiveness of pharmacotherapies in early Parkinson's disease.
CNS drugs 2008;22(10):841-60.
2008: Unger Marcus M; Reese Jens P; Oertel Wolfgang H; Eggert Karla M
Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease.
European neurology 2008;60(3):122-6.
2008: Oertel Wolfgang; Poewe Werner; Wolters Erik; De Deyn Peter Paul; Emre Murat; Kirsch Courtney; Hsu Chuanchieh; Tekin Sibel; Lane Roger
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(1):79-94.
2007: Wüllner U; Schmitz-Hübsch T; Antony G; Fimmers R; Spottke A; Oertel W H; Deuschl G; Klockgether T; Eggert K;
Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(12):1405-8.
2007: Stiasny-Kolster Karin; Mayer Geert; Schäfer Sylvia; Möller Jens Carsten; Heinzel-Gutenbrunner Monika; Oertel Wolfgang H
The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2386-93.
2007: Knake S; Klein K M; Hattemer K; Wellek A; Oertel W H; Hamer H M; Rosenow F
Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain.
Epilepsy & behavior : E&B 2007;11(3):471-3.
2007: Arias-Carrión Oscar; Freundlieb Nils; Oertel Wolfgang H; Höglinger Günter U
Adult neurogenesis and Parkinson's disease.
CNS & neurological disorders drug targets 2007;6(5):326-35.
2007: Alvarez-Fischer D; Blessmann G; Trosowski C; Béhé M; Schurrat T; Hartmann A; Behr T M; Oertel W H; Höglinger G U; Höffken H
Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
NeuroImage 2007;38(1):5-12.
2007: Lees A J; Ratziu V; Tolosa E; Oertel W H
Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(9):944-8.
2007: Winkelmann Juliane; Schormair Barbara; Lichtner Peter; Ripke Stephan; Xiong Lan; Jalilzadeh Shapour; Fulda Stephany; Pütz Benno; Eckstein Gertrud; Hauk Stephanie; Trenkwalder Claudia; Zimprich Alexander; Stiasny-Kolster Karin; Oertel Wolfgang; Bachmann Cornelius G; Paulus Walter; Peglau Ines; Eisensehr Ilonka; Montplaisir Jacques; Turecki Gustavo; Rouleau Guy; Gieger Christian; Illig Thomas; Wichmann H-Erich; Holsboer Florian; Müller-Myhsok Bertram; Meitinger Thomas
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
Nature genetics 2007;39(8):1000-6.
2007: Krebs Bjarne; Bader Benedikt; Klehmet Juliane; Grasbon-Frodl Eva; Oertel Wolfgang H; Zerr Inga; Stricker Sarah; Zschenderlein Rolf; Kretzschmar Hans A
A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment.
Acta neuropathologica 2007;114(2):195-9.
2007: García-Borreguero Diego; Allen Richard P; Kohnen Ralf; Högl Birgit; Trenkwalder Claudia; Oertel Wolfgang; Hening Wayne A; Paulus Walter; Rye David; Walters Arthur; Winkelmann Juliane; Earley Christopher J;
Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
Sleep medicine 2007;8(5):520-30.
2007: Oertel Wolfgang; Ross Joel S; Eggert Karla; Adler Georg
Rationale for transdermal drug administration in Alzheimer disease.
Neurology 2007;69(4 Suppl 1):S4-9.
2007: Escobar-Khondiker Myriam; Höllerhage Matthias; Muriel Marie-Paule; Champy Pierre; Bach Antoine; Depienne Christel; Respondek Gesine; Yamada Elizabeth S; Lannuzel Annie; Yagi Takao; Hirsch Etienne C; Oertel Wolfgang H; Jacob Ralf; Michel Patrick P; Ruberg Merle; Höglinger Günter U
Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(29):7827-37.
2007: Storch Alexander; Jost Wolfgang H; Vieregge Peter; Spiegel Jörg; Greulich Wolfgang; Durner Joachim; Müller Thomas; Kupsch Andreas; Henningsen Henning; Oertel Wolfgang H; Fuchs Gerd; Kuhn Wilfried; Niklowitz Petra; Koch Rainer; Herting Birgit; Reichmann Heinz;
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Archives of neurology 2007;64(7):938-44.
2007: Scherfler Christoph; Schwarz Johannes; Antonini Angelo; Grosset Donald; Valldeoriola Francesc; Marek Kenneth; Oertel Wolfgang; Tolosa Eduardo; Lees Andrew J; Poewe Werner
Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1229-38.
2007: Poewe Werner H; Rascol Olivier; Quinn Niall; Tolosa Eduardo; Oertel Wolfgang H; Martignoni Emilia; Rupp Markus; Boroojerdi Babak;
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.
Lancet neurology 2007;6(6):513-20.
2007: Tackenberg B; Himmerich H; Wellek A; Oertel W H; Sommer N
[Advances in the treatment of multiple sclerosis?]
MMW Fortschritte der Medizin 2007;149 Suppl 2():51-5.
2007: Pfütze Martin; Reis Janine; Haag Anja; John Daniel; Hattemer Katja; Oertel Wolfgang H; Rosenow Felix; Hamer Hajo M
Lack of differences of motorcortical excitability in the morning as compared to the evening in juvenile myoclonic epilepsy--a study using transcranial magnetic stimulation.
Epilepsy research 2007;74(2-3):239-42.
2007: Hasselbalch S G; Baloyannis S; Denislic M; Dubois B; Oertel W; Rossor M; Tsiskaridze A; Waldemar G
Education and training of European neurologists in dementia.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(5):505-9.
2007: Tackenberg Björn; Metz Aline; Unger Marcus; Schimke Nicole; Passow Sebastian; Hoeffken Helmut; Hoffmann Georg F; Müller Ulrich; Nolte Dagmar; Oertel Wolfgang H; Eggert Karla; Möller Jens Carsten
Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
Movement disorders : official journal of the Movement Disorder Society 2007;22(6):900-2.
2007: Eggert Karla; Wüllner Ullrich; Antony Gisela; Gasser Thomas; Janetzky Bernd; Klein Christine; Schöls Ludger; Oertel Wolfgang
Data protection in biomaterial banks for Parkinson's disease research: the model of GEPARD (Gene Bank Parkinson's Disease Germany).
Movement disorders : official journal of the Movement Disorder Society 2007;22(5):611-8.
2007: Tackenberg Björn; Kruth Jens; Bartholomaeus Johanna E; Schlegel Kerstin; Oertel Wolfgang H; Willcox Nicholas; Hemmer Bernhard; Sommer Norbert
Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis.
European journal of immunology 2007;37(3):849-63.
2007: Lannuzel Annie; Höglinger G U; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel W H; Hirsch E C; Dubois B; Ruberg M
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Brain : a journal of neurology 2007;130(Pt 3):816-27.
2007: Hattemer Katja; Knake Susanne; Reis Janine; Rochon Justine; Oertel Wolfgang H; Rosenow Felix; Hamer Hajo M
Excitability of the motor cortex during ovulatory and anovulatory cycles: a transcranial magnetic stimulation study.
Clinical endocrinology 2007;66(3):387-93.
2007: Walters Arthur S; Elin Ronald J; Cohen Barry; Moller Jens Carsten; Oertel Wolfgang; Stiasny-Kolster Karin
Magnesium not likely to play a major role in the pathogenesis of Restless Legs Syndrome: serum and cerebrospinal fluid studies.
Sleep medicine 2007;8(2):186-7.
2007: Mylius Veit; Reis Janine; Knaack Anne; Haag Anja; Oertel Wolfgang H; Rosenow Felix; Schepelmann Karsten
High-frequency rTMS of the motor cortex does not influence the nociceptive flexion reflex but increases the unpleasantness of electrically induced pain.
Neuroscience letters 2007;415(1):49-54.
2007: Höglinger Günter U; Breunig Joshua J; Depboylu Candan; Rouaux Caroline; Michel Patrick P; Alvarez-Fischer Daniel; Boutillier Anne-Laurence; Degregori James; Oertel Wolfgang H; Rakic Pasko; Hirsch Etienne C; Hunot Stéphane
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3585-90.
2007: Stiasny-Kolster K; Clever S-C; Möller J C; Oertel W H; Mayer G
Olfactory dysfunction in patients with narcolepsy with and without REM sleep behaviour disorder.
Brain : a journal of neurology 2007;130(Pt 2):442-9.
2007: Czlonkowska Anna; Tarnacka Beata; Möller Jens Carsten; Leinweber Barbara; Bandmann Oliver; Woimant France; Oertel Wolfgang H
Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients.
Neurologia i neurochirurgia polska 2007;41(1):1-12.
2007: Oertel Wolfgang H; Stiasny-Kolster Karin; Bergtholdt Bettina; Hallström Yngve; Albo Jaan; Leissner Lena; Schindler Thomas; Koester Juergen; Reess Juergen;
Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):213-9.
2007: Kemlink David; Polo Olli; Montagna Pasquale; Provini Federica; Stiasny-Kolster Karin; Oertel Wolfgang; de Weerd Al; Nevsimalova Sona; Sonka Karel; Högl Birgit; Frauscher Birgit; Poewe Werner; Trenkwalder Claudia; Pramstaller Peter P; Ferini-Strambi Luigi; Zucconi Marco; Konofal Eric; Arnulf Isabelle; Hadjigeorgiou Georgios M; Happe Svenja; Klein Christine; Hiller Anja; Lichtner Peter; Meitinger Thomas; Müller-Myshok Betram; Winkelmann Juliane
Family-based association study of the restless legs syndrome loci 2 and 3 in a European population.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):207-12.
2007: Möller J Carsten; Oertel Wolfgang H
Other degenerative processes.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():445-57.
2007: Trenkwalder Claudia; Oertel Wolfgang H; Allen Richard; Garcia-Borreguero Diego
Tireless work on restless legs: guest editors' introduction.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 18():S393-4.
2007: Depboylu Candan; Matusch Andreas; Tribl Florian; Zoriy Myroslav; Michel Patrick P; Riederer Peter; Gerlach Manfred; Becker Sabine; Oertel Wolfgang H; Höglinger Günter U
Glia protects neurons against extracellular human neuromelanin.
Neuro-degenerative diseases 2007;4(2-3):218-26.
2007: Winkelmann Juliane; Polo Oli; Provini Federica; Nevsimalova Sonja; Kemlink David; Sonka Karel; Högl Birgit; Poewe Werner; Stiasny-Kolster Karin; Oertel Wolfgang; de Weerd Al; Strambi Luigi Ferini; Zucconi Marco; Pramstaller Peter P; Arnulf Isabelle; Trenkwalder Claudia; Klein Christine; Hadjigeorgiou Georgios M; Happe Svenja; Rye David; Montagna Pasquale
Genetics of restless legs syndrome (RLS): State-of-the-art and future directions.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 18():S449-58.
2007: Iranzo Alex; Comella Cynthia L; Santamaria Joan; Oertel Wolfgang
Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 18():S424-30.
2007: Trenkwalder Claudia; Kohnen Ralf; Allen Richard P; Benes Heike; Ferini-Strambi Luigi; Garcia-Borreguero Diego; Hadjigeorgiou Georgios M; Happe Svenja; Högl Birgit; Hornyak Magdolna; Klein Christine; Nass Alexander; Montagna Pasquale; Oertel Wolfgang H; O'Keeffe Shaun; Paulus Walter; Poewe Werner; Provini Federica; Pramstaller Peter P; Sieminski Mariusz; Sonka Karel; Stiasny-Kolster Karin; de Weerd Al; Wetter Thomas C; Winkelmann Juliane; Zucconi Marco
Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG).
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 18():S495-504.
2007: Oertel Wolfgang H; Trenkwalder Claudia; Zucconi Marco; Benes Heike; Borreguero Diego Garcia; Bassetti Claudio; Partinen Markku; Ferini-Strambi Luigi; Stiasny-Kolster Karin
State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 18():S466-75.
2006: Hamer Hajo M; Spottke Annika; Aletsee Christiane; Knake Susanne; Reis Janine; Strzelczyk Adam; Oertel Wolfgang H; Rosenow Felix; Dodel Richard
Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Epilepsia 2006;47(12):2165-72.
2006: Knake Susanne; Rochon Justine; Fleischer Sarah; Katsarou Niki; Back Tobias; Vescovi Mathias; Oertel Wolfgang H; Reis Janine; Hamer Hajo M; Rosenow Felix
Status epilepticus after stroke is associated with increased long-term case fatality.
Epilepsia 2006;47(12):2020-6.
2006: Tackenberg B; Möller J C; Rindock H; Bien S; Sommer N; Oertel W H; Rosenow F; Schepelmann K; Hamer H M; Bandmann O
CNS involvement in hereditary neuropathy with pressure palsies (HNPP).
Neurology 2006;67(12):2250-2.
2006: Hattemer Katja; Knake Susanne; Reis Janine; Oertel Wolfgang H; Rosenow Felix; Hamer Hajo M
Cyclical excitability of the motor cortex in patients with catamenial epilepsy: a transcranial magnetic stimulation study.
Seizure : the journal of the British Epilepsy Association 2006;15(8):653-7.
2006: Reis Janine; John Daniel; Heimeroth Antje; Mueller Hans-Helge; Oertel Wolfgang H; Arndt Torsten; Rosenow Felix
Modulation of human motor cortex excitability by single doses of amantadine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(12):2758-66.
2006: Stacy Mark; Hauser Robert; Oertel Wolfgang; Schapira Anthony; Sethi Kapil; Stocchi Fabrizio; Tolosa Eduardo
End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
Clinical neuropharmacology 2006;29(6):312-21.
2006: Möller J Carsten; Oertel Wolfgang H
Use of nutritional supplements in patients with Parkinson's disease: a cause for concern?
Nature clinical practice. Neurology 2006;2(11):598-9.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1186-202.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1170-85.
2006: Möller Jens Carsten; Leinweber Barbara; Rissling Ida; Oertel Wolfgang Herman; Bandmann Oliver; Schmidt Hartmut H-J
Prevalence of the H1069Q mutation in ATP7B in discordant pairs with early-onset Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1789-90.
2006: Oertel W H; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Neurology 2006;67(6):1040-6.
2006: Knake Susanne; Haag Anja; Pilgramm Guido; Dittmer Christine; Reis Janine; Assmann Heike; Oertel Wolfgang H; Rosenow Felix; Hamer Hajo M
Language dominance in mesial temporal lobe epilepsy: a functional transcranial Doppler sonography study of brain plasticity.
Epilepsy & behavior : E&B 2006;9(2):345-8.
2006: Trenkwalder Claudia; Stiasny-Kolster Karin; Kupsch Andreas; Oertel Wolfgang H; Koester Juergen; Reess Juergen
Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
Movement disorders : official journal of the Movement Disorder Society 2006;21(9):1404-10.
2006: Stiasny-Kolster Karin; Kohnen Ralf; Möller Jens Carsten; Trenkwalder Claudia; Oertel Wolfgang H
Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
Movement disorders : official journal of the Movement Disorder Society 2006;21(9):1333-9.
2006: Deuschl Günther; Schade-Brittinger Carmen; Krack Paul; Volkmann Jens; Schäfer Helmut; Bötzel Kai; Daniels Christine; Deutschländer Angela; Dillmann Ulrich; Eisner Wilhelm; Gruber Doreen; Hamel Wolfgang; Herzog Jan; Hilker Rüdiger; Klebe Stephan; Kloss Manja; Koy Jan; Krause Martin; Kupsch Andreas; Lorenz Delia; Lorenzl Stefan; Mehdorn H Maximilian; Moringlane Jean Richard; Oertel Wolfgang; Pinsker Marcus O; Reichmann Heinz; Reuss Alexander; Schneider Gerd-Helge; Schnitzler Alfons; Steude Ulrich; Sturm Volker; Timmermann Lars; Tronnier Volker; Trottenberg Thomas; Wojtecki Lars; Wolf Elisabeth; Poewe Werner; Voges Jürgen;
A randomized trial of deep-brain stimulation for Parkinson's disease.
The New England journal of medicine 2006;355(9):896-908.
2006: Mylius Veit; Reis Janine; Kunz Miriam; Beyer Thomas F; Oertel Wolfgang H; Rosenow Felix; Schepelmann Karsten
Modulation of electrically induced pain by paired pulse transcranial magnetic stimulation of the medial frontal cortex.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2006;117(8):1814-20.
2006: Lu Lixia; Neff Frauke; Fischer Daniel Alvarez; Henze Carmen; Hirsch Etienne C; Oertel Wolfgang H; Schlegel Jürgen; Hartmann Andreas
Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Neurobiology of disease 2006;23(2):409-21.
2006: Möller Jens Carsten; Körner Yvonne; Cassel Werner; Meindorfner Charlotte; Krüger Hans-Peter; Oertel Wolfgang H; Stiasny-Kolster Karin
Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
Sleep medicine 2006;7(4):333-9.
2006: Schrag Anette; Geser Felix; Stampfer-Kountchev Michaela; Seppi Klaus; Sawires Martin; Köllensperger Martin; Scherfler Christoph; Quinn Niall; Pellecchia Maria T; Barone Paolo; Del Sorbo Francesca; Albanese Alberto; Ostergaard Karen; Dupont Erik; Cardozo Adriana; Tolosa Eduardo; Nilsson Christer F; Widner Håkan; Lindvall Olle; Giladi Nir; Gurevich Tanya; Daniels Christine; Deuschl Günther; Coelho Miguel; Sampaio Cristina; Abele Michael; Klockgether Thomas; Schimke Nicole; Eggert Karla M; Oertel Wolfgang; Djaldetti Ruth; Colosimo Carlo; Meco Giuseppe; Poewe Werner; Wenning Gregor K;
Health-related quality of life in multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2006;21(6):809-15.
2006: Möller Jens Carsten; Krüttgen Alex; Burmester Rosi; Weis Joachim; Oertel Wolfgang H; Shooter Eric M
Release of interleukin-6 via the regulated secretory pathway in PC12 cells.
Neuroscience letters 2006;400(1-2):75-9.
2006: Pogarell Oliver; Koch Walter; Gildehaus Franz J; Kupsch Andreas; Lindvall Olle; Oertel Wolfgang H; Tatsch Klaus
Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts.
European journal of nuclear medicine and molecular imaging 2006;33(4):407-11.
2006: Chen Xu; Sure Ulrich; Haag Anja; Knake Susanne; Fritsch Brita; Müller Hans-Helge; Becker Ralf; Oertel Wolfgang H; Bertalanffy Helmut; Hamer Hajo M; Rosenow Felix
Predictive value of electrocorticography in epilepsy patients with unilateral hippocampal sclerosis undergoing selective amygdalohippocampectomy.
Neurosurgical review 2006;29(2):108-13.
2006: Oertel Wolfgang H; Wolters Erik; Sampaio Cristina; Gimenez-Roldan Santiago; Bergamasco Bruno; Dujardin Max; Grosset Donald G; Arnold Guy; Leenders Klaus L; Hundemer Hans-Peter; Lledó Alberto; Wood Andrew; Frewer Paul; Schwarz Johannes
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(3):343-53.
2006: Freundlieb Nils; François Chantal; Tandé Dominique; Oertel Wolfgang H; Hirsch Etienne C; Höglinger Günter U
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(8):2321-5.
2006: Gerhard Alexander; Pavese Nicola; Hotton Gary; Turkheimer Federico; Es Meltem; Hammers Alexander; Eggert Karla; Oertel Wolfgang; Banati Richard B; Brooks David J
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Neurobiology of disease 2006;21(2):404-12.
2006: Geser Felix; Wenning Gregor K; Seppi Klaus; Stampfer-Kountchev Michaela; Scherfler Christoph; Sawires Martin; Frick Carolin; Ndayisaba Jean-Pierre; Ulmer Hanno; Pellecchia Maria T; Barone Paolo; Kim Hee T; Hooker Juzar; Quinn Niall P; Cardozo Adriana; Tolosa Eduardo; Abele Michael; Klockgether Thomas; Østergaard Karen; Dupont Erik; Schimke Nicole; Eggert Karla M; Oertel Wolfgang; Djaldetti Ruth; Poewe Werner;
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
Movement disorders : official journal of the Movement Disorder Society 2006;21(2):179-86.
2006: Rissling Ida; Frauscher Birgit; Kronenberg Florian; Tafti Mehdi; Stiasny-Kolster Karin; Robyr Anne-Catherine; Körner Yvonne; Oertel Wolfgang Hermann; Poewe Werner; Högl Birgit; Möller Jens Carsten
Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease.
Sleep 2006;29(1):108-11.
2006: Tackenberg Björn; Möller J Carsten; Eggert Karla; Sommer Norbert; Oertel Wolfgang H
Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):126-7.
2006: Höglinger G U; Oertel W H; Hirsch E C
The rotenone model of parkinsonism--the five years inspection.
Journal of neural transmission. Supplementum 2006;(70):269-72.
2005: Piccini Paola; Pavese Nicola; Hagell Peter; Reimer Jan; Björklund Anders; Oertel Wolfgang H; Quinn Niall P; Brooks David J; Lindvall Olle
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Brain : a journal of neurology 2005;128(Pt 12):2977-86.
2005: Möller J Carsten; Rethfeldt Mira; Körner Yvonne; Stiasny-Kolster Karin; Cassel Werner; Meindorfner Charlotte; Rissling Ida; Krüger Hans-Peter; Oertel Wolfgang H
Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep.
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1620-2.
2005: Geser F; Seppi K; Stampfer-Kountchev M; Köllensperger M; Diem A; Ndayisaba J P; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Dodel R; Klockgether T; Ghorayeb I; Yekhlef F; Tison F; Daniels C; Kopper F; Deuschl G; Coelho M; Ferreira J; Rosa M M; Sampaio C; Bozi M; Schrag A; Hooker J; Kim H; Scaravilli T; Mathias C J; Fowler C; Wood N; Quinn N; Widner H; Nilsson C F; Lindvall O; Schimke N; Eggert K M; Oertel W; del Sorbo F; Carella F; Albanese A; Pellecchia M T; Barone P; Djaldetti R; Meco G; Colosimo C; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Ory F; Rascol O; Kamm C; Buerk K; Maass S; Gasser T; Poewe W; Wenning G K;
The European Multiple System Atrophy-Study Group (EMSA-SG).
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(12):1677-86.
2005: Höglinger Günter U; Lannuzel Annie; Khondiker Myriam Escobar; Michel Patrick P; Duyckaerts Charles; Féger Jean; Champy Pierre; Prigent Annick; Medja Fadia; Lombes Anne; Oertel Wolfgang H; Ruberg Merle; Hirsch Etienne C
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Journal of neurochemistry 2005;95(4):930-9.
2005: Healy Daniel G; Abou-Sleiman Patrick M; Quinn Niall; Ahmadi Kourosh R; Ozawa Tetsutaro; Kamm Christoph; Wullner Ullrich; Oertel Wolfgang H; Burk Katrin; Dupont Erik; Pellecchia Maria T; Tolosa Eduardo; Gasser Thomas; Holton Janice L; Revesz Tamas; Goldstein David B; Lees Andrew J; Wood Nicholas W;
UCHL-1 gene in multiple system atrophy: a haplotype tagging approach.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1338-43.
2005: Möller J Carsten; Oertel Wolfgang H
Pramipexole in the treatment of Parkinson's disease: new developments.
Expert review of neurotherapeutics 2005;5(5):581-6.
2005: Lu Lixia; Neff Frauke; Alvarez-Fischer Daniel; Henze Carmen; Xie Yanhui; Oertel Wolfgang H; Schlegel Jürgen; Hartmann Andreas
Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
Experimental neurology 2005;195(1):27-39.
2005: Berg Daniela; Niwar Marc; Maass Sylvia; Zimprich Alexander; Möller J Carsten; Wuellner Ullrich; Schmitz-Hübsch Tanja; Klein Christine; Tan Eng-King; Schöls Ludger; Marsh Laura; Dawson Ted M; Janetzky Bernd; Müller Thomas; Woitalla Dirk; Kostic Vladimir; Pramstaller Peter P; Oertel Wolfgang H; Bauer Peter; Krueger Rejko; Gasser Thomas; Riess Olaf
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1191-4.
2005: Brandstaedter D; Spieker S; Ulm G; Siebert U; Eichhorn T E; Krieg J C; Oertel W H; Eggert K
Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease.
Journal of neurology 2005;252(9):1060-6.
2005: Klein Karl Martin; Hamer Hajo M; Reis Janine; Schmidtke Jörg; Oertel Wolfgang H; Theisen Frank M; Hebebrand Johannes; Rosenow Felix
Weight change in monozygotic twins treated with valproate.
Obesity research 2005;13(8):1330-4.
2005: Henze Carmen; Earl Christopher; Sautter Jürgen; Schmidt Nicole; Themann Claudia; Hartmann Andreas; Oertel Wolfgang H
Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
Brain research 2005;1052(1):97-104.
2005: von Campenhausen Sonja; Bornschein Bernhard; Wick Regina; Bötzel Kai; Sampaio Cristina; Poewe Werner; Oertel Wolfgang; Siebert Uwe; Berger Karin; Dodel Richard
Prevalence and incidence of Parkinson's disease in Europe.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(4):473-90.
2005: Möller J C; Körner Y; Dodel R C; Meindorfner C; Stiasny-Kolster K; Spottke A; Krüger H P; Oertel W H
Pharmacotherapy of Parkinson's disease in Germany.
Journal of neurology 2005;252(8):926-35.
2005: Rissling Ida; Körner Yvonne; Geller Frank; Stiasny-Kolster Karin; Oertel Wolfgang H; Möller J Carsten
Preprohypocretin polymorphisms in Parkinson disease patients reporting "sleep attacks".
Sleep 2005;28(7):871-5.
2005: Meindorfner Charlotte; Körner Yvonne; Möller Jens Carsten; Stiasny-Kolster Karin; Oertel Wolfgang Hermann; Krüger Hans-Peter
Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel.
Movement disorders : official journal of the Movement Disorder Society 2005;20(7):832-42.
2005: Stacy Mark; Bowron Annette; Guttman Mark; Hauser Robert; Hughes Kim; Larsen Jan Petter; LeWitt Peter; Oertel Wolfgang; Quinn Niall; Sethi Kapil; Stocchi Fabrizio
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):726-33.
2005: Möller J Carsten; Oertel Wolfgang H; Köster Jürgen; Pezzoli Gianni; Provinciali Leandro
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):602-10.
2005: Hamer H M; Reis J; Mueller H-H; Knake S; Overhof M; Oertel W H; Rosenow F
Motor cortex excitability in focal epilepsies not including the primary motor area--a TMS study.
Brain : a journal of neurology 2005;128(Pt 4):811-8.
2005: Rascol O; Brooks D J; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E;
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Lancet 2005;365(9463):947-54.
2005: Reis J; Rosenow F; Fritsch B; Knake S; Oertel W H; Hamer H M
Possible transcallosal seizure induction by paired pulse transcranial magnetic stimulation in a patient with frontal lobe epilepsy.
Journal of neurology, neurosurgery, and psychiatry 2005;76(3):454-5.
2005: Ravina B; Eidelberg D; Ahlskog J E; Albin R L; Brooks D J; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz R G; Kieburtz K; Kish S J; Lange N; Langston J W; Marek K; Morin L; Moy C; Murphy D; Oertel W H; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi K D; Shults C W; Sheehy P; Stoessl A J; Holloway R
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Stiasny-Kolster K; Doerr Y; Möller J C; Höffken H; Behr T M; Oertel W H; Mayer G
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Brain : a journal of neurology 2005;128(Pt 1):126-37.
2005: Spottke Annika E; Reuter Martin; Machat Olaf; Bornschein Bernhard; von Campenhausen Sonja; Berger Karin; Koehne-Volland Rudolf; Rieke Jürgen; Simonow Alexander; Brandstaedter Dirk; Siebert Uwe; Oertel Wolfgang H; Ulm Gudrun; Dodel Richard
Cost of illness and its predictors for Parkinson's disease in Germany.
PharmacoEconomics 2005;23(8):817-36.
2005: Fuhrmann Markus; Oertel Wolfgang; Berthold Peter; Hegemann Peter
Removal of mismatched bases from synthetic genes by enzymatic mismatch cleavage.
Nucleic acids research 2005;33(6):e58.
2004: Stiasny-Kolster K; Benes H; Peglau I; Hornyak M; Holinka B; Wessel K; Emser W; Leroux M; Kohnen R; Oertel W H
Effective cabergoline treatment in idiopathic restless legs syndrome.
Neurology 2004;63(12):2272-9.
2004: Wei Xing; Zhao Liming; Ma Zhizhong; Holtzman David M; Yan Chong; Dodel Richard C; Hampel Harald; Oertel Wolfgang; Farlow Martin R; Du Yansheng
Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury.
Brain : a journal of neurology 2004;127(Pt 12):2629-35.
2004: Stiasny-Kolster Karin; Kohnen Ralf; Schollmayer Erwin; Möller J Carsten; Oertel Wolfgang H;
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1432-8.
2004: Knake Susanne; Haag Anja; Pilgramm Guido; Reis Janine; Klein Karl M; Hoeffken Helmut; Bartenstein Peter; Oertel Wolfgang H; Hamer Hajo M; Rosenow Felix
Ictal functional TCD for the lateralization of the seizure onset zone--a report of two cases.
Epilepsy research 2004;62(1):89-93.
2004: Reis Janine; Wentrup Andreas; Hamer Hajo M; Mueller Hans-Helge; Knake Susanne; Tergau Frithjof; Oertel Wolfgang H; Rosenow Felix
Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function--a TMS study.
Epilepsy research 2004;62(1):41-51.
2004: Rissling Ida; Geller Frank; Bandmann Oliver; Stiasny-Kolster Karim; Körner Yvonne; Meindorfner Charlotte; Krüger Hans-Peter; Oertel Wolfgang H; Möller J Carsten
Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Movement disorders : official journal of the Movement Disorder Society 2004;19(11):1279-84.
2004: Körner Yvonne; Meindorfner Charlotte; Möller Jens Carsten; Stiasny-Kolster Karin; Haja Doris; Cassel Werner; Oertel Wolfgang Hermann; Krüger Hans-Peter
Predictors of sudden onset of sleep in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2004;19(11):1298-305.
2004: Dodel R C; Du Y; Depboylu C; Hampel H; Frölich L; Haag A; Hemmeter U; Paulsen S; Teipel S J; Brettschneider S; Spottke A; Nölker C; Möller H J; Wei X; Farlow M; Sommer N; Oertel W H
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1472-4.
2004: Stiasny-Kolster K; Trenkwalder C; Fogel W; Greulich W; Hahne M; Lachenmayer L; Oechsner M; Oertel W H
Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment options.
Journal of neurology 2004;251 Suppl 6():VI/39-43.
2004: Dodel Richard; Peter Helga; Walbert Tobias; Spottke Annika; Noelker Carmen; Berger Karin; Siebert Uwe; Oertel Wolfgang H; Kesper Karl; Becker Heinrich F; Mayer Geert
The socioeconomic impact of narcolepsy.
Sleep 2004;27(6):1123-8.
2004: Hoffmann Steve; Becker Andreas; Hoerle Steffen; Metz Aline; Oertel Wolfgang H; Sommer Norbert; Hemmer Bernhard
Autosomal dominant congenital nystagmus is not linked to 6p12, 7p11, and 15q11 in a German family.
American journal of ophthalmology 2004;138(3):439-43.
2004: Höglinger Günter U; Rizk Pamela; Muriel Marie P; Duyckaerts Charles; Oertel Wolfgang H; Caille Isabelle; Hirsch Etienne C
Dopamine depletion impairs precursor cell proliferation in Parkinson disease.
Nature neuroscience 2004;7(7):726-35.
2004: Höglinger Günter U; Rissling Ida; Metz Aline; Ries Vincent; Heinermann Anne; Prinz Helge; Spieker Sybille; Deuschl Günter; Baum Erika; Oertel Wolfgang H
Enhancing recognition of early Parkinsonism in the community.
Movement disorders : official journal of the Movement Disorder Society 2004;19(5):505-12.
2004: Grundmann M; Earl C D; Sautter J; Henze C; Oertel W H; Bandmann O
Slow N-acetyltransferase 2 status leads to enhanced intrastriatal dopamine depletion in 6-hydroxydopamine-lesioned rats.
Experimental neurology 2004;187(1):199-202.
2004: Lu Lixia; Neff Frauke; Dun Zhou; Hemmer Bernhard; Oertel Wolfgang H; Schlegel Jürgen; Hartmann Andreas
Gene expression profiles derived from single cells in human postmortem brain.
Brain research. Brain research protocols 2004;13(1):18-25.
2004: Möller Jens Carsten; Depboylu Candan; Kölsch Heike; Lohmüller Frank; Bandmann Oliver; Gocke Petra; Du Yansheng; Paus Sebastian; Wüllner Ullrich; Gasser Thomas; Oertel Wolfgang H; Klockgether Thomas; Dodel Richard C
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease.
Neuroscience letters 2004;359(3):195-7.
2004: Stiasny-Kolster K; Magerl W; Oertel W H; Möller J C; Treede R-D
Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome.
Brain : a journal of neurology 2004;127(Pt 4):773-82.
2004: Dodel Richard C; Haacke Caroline; Zamzow Karin; Paweilik Sven; Spottke Annika; Rethfeldt Mira; Siebert Uwe; Oertel Wolfgang H; Schöffski Oliver; Back Tobias
Resource utilization and costs of stroke unit care in Germany.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(2):144-52.
2004: Stiasny-Kolster Karin; Möller J Carsten; Zschocke Johannes; Bandmann Oliver; Cassel Werner; Oertel Wolfgang H; Hoffmann Georg F
Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.
Movement disorders : official journal of the Movement Disorder Society 2004;19(2):192-6.
2004: Stiasny-Kolster Karin; Oertel Wolfgang H
Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Neuropsychobiology 2004;50(1):65-70.
2003: Möller J C; Sünkeler I H; Oertel W H; Mennel H D
[Pigmented form of orthochromatic leukodystrophy]
Der Nervenarzt 2003;74(12):1127-33.
2003: Depino Amaicha M; Earl Chris; Kaczmarczyk Elke; Ferrari Carina; Besedovsky Hugo; del Rey Adriana; Pitossi Fernando J; Oertel Wolfgang H
Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.
The European journal of neuroscience 2003;18(10):2731-42.
2003: Stiasny-Kolster K; Mignot E; Ling L; Möller J C; Cassel W; Oertel W H
CSF hypocretin-1 levels in restless legs syndrome.
Neurology 2003;61(10):1426-9.
2003: Sibbing D; Asmus F; König I R; Tezenas du Montcel S; Vidailhet M; Sangla S; Oertel W H; Brice A; Ziegler A; Gasser T; Bandmann O
Candidate gene studies in focal dystonia.
Neurology 2003;61(8):1097-101.
2003: Trenkwalder Claudia; Collado Seidel Victor; Kazenwadel Jörg; Wetter Thomas C; Oertel Wolfgang; Selzer Roland; Kohnen Ralf
One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
Movement disorders : official journal of the Movement Disorder Society 2003;18(10):1184-9.
2003: Dodel Richard C; Höffken Helmut; Möller J Carsten; Bornschein Bernhard; Klockgether Thomas; Behr Thomas; Oertel Wolfgang H; Siebert Uwe
Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
Movement disorders : official journal of the Movement Disorder Society 2003;18 Suppl 7():S52-62.
2003: Oertel Wolfgang H; Gerstner Anja; Höffken Helmut; Dodel Richard C; Eggert Karla M; Möller Jens C
Role of dopamine transporter SPECT for the practitioner and the general neurologist.
Movement disorders : official journal of the Movement Disorder Society 2003;18 Suppl 7():S9-15.
2003: Klein Karl Martin; Knake Susanne; Hamer Hajo M; Ziegler Andreas; Oertel Wolfgang H; Rosenow Felix
Sleep but not hyperventilation increases the sensitivity of the EEG in patients with temporal lobe epilepsy.
Epilepsy research 2003;56(1):43-9.
2003: Benamer Hani T S; Oertel Wolfgang H; Patterson Jim; Hadley Donald M; Pogarell Oliver; Höffken H; Gerstner A; Grosset Donald G
Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
Movement disorders : official journal of the Movement Disorder Society 2003;18(9):977-84.
2003: Du Yansheng; Wei Xing; Dodel Richard; Sommer Norbert; Hampel Harald; Gao Feng; Ma Zhizhong; Zhao Liming; Oertel Wolfgang H; Farlow Martin
Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity.
Brain : a journal of neurology 2003;126(Pt 9):1935-9.
2003: Smala Antje M; Spottke E Annika; Machat Olaf; Siebert Uwe; Meyer Dieter; Köhne-Volland Rudolf; Reuther Martin; DuChane Janeen; Oertel Wolfgang H; Berger Karin B; Dodel Richard C
Cabergoline versus levodopa monotherapy: a decision analysis.
Movement disorders : official journal of the Movement Disorder Society 2003;18(8):898-905.
2003: Knake Susanne; Haag Anja; Hamer Hajo M; Dittmer Christine; Bien Siegfried; Oertel Wolfgang H; Rosenow Felix
Language lateralization in patients with temporal lobe epilepsy: a comparison of functional transcranial Doppler sonography and the Wada test.
NeuroImage 2003;19(3):1228-32.
2003: Depboylu Candan; Du Yansheng; Müller Ulrich; Kurz Alexander; Zimmer Reinhilde; Riemenschneider Matthias; Gasser Thomas; Oertel Wolfgang H; Klockgether Thomas; Dodel Richard C;
Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease.
Neuroscience letters 2003;342(1-2):132-4.
2003: Schoenian Sarah; Konig Inke; Oertel Wolfgang; Remschmidt Helmut; Ziegler Andreas; Hebebrand Johannes; Bandmann Oliver
HLA-DRB genotyping in Gilles de la Tourette patients and their parents.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;119B(1):60-4.
2003: Back Tobias; Möckel Regina; Hirsch Jochen G; Gaa Jochen; Oertel Wolfgang H; Hennerici Michael G; Gass Achim
Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases.
Neurological research 2003;25(3):292-300.
2003: Oertel Wolfgang H; Wächter Tobias; Quinn Niall P; Ulm Gudrun; Brandstädter Dirk
Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type.
Movement disorders : official journal of the Movement Disorder Society 2003;18(4):430-2.
2003: Tackenberg B; Nitschke M; Willcox N; Ziegler A; Nessler S; Schumm F; Oertel W H; Hemmer B; Sommer N
CD45 isoform expression in autoimmune myasthenia gravis.
Autoimmunity 2003;36(2):117-21.
2003: Hock Christoph; Maddalena Alessia; Raschig Andreas; Müller-Spahn Franz; Eschweiler Gerhard; Hager Klaus; Heuser Isabella; Hampel Harald; Müller-Thomsen Thomas; Oertel Wolfgang; Wienrich Marion; Signorell Andri; Gonzalez-Agosti Charo; Nitsch Roger M
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(1):1-6.
2003: Hamer H M; Lüders H O; Knake S; Fritsch B; Oertel W H; Rosenow F
Electrophysiology of focal clonic seizures in humans: a study using subdural and depth electrodes.
Brain : a journal of neurology 2003;126(Pt 3):547-55.
2003: Bandmann O; Goertz M; Zschocke J; Deuschl G; Jost W; Hefter H; Müller U; Zöfel P; Hoffmann G; Oertel W
The phenylalanine loading test in the differential diagnosis of dystonia.
Neurology 2003;60(4):700-2.
2003: Höglinger Günter U; Féger Jean; Prigent Annick; Michel Patrick P; Parain Karine; Champy Pierre; Ruberg Merle; Oertel Wolfgang H; Hirsch Etienne C
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Journal of neurochemistry 2003;84(3):491-502.
2003: Sibbing Dirk; Trender-Gerhardt Iris; Wood Nick W; Oertel Wolfgang H; Bhatia Kailash P; Bandmann Oliver
The promoter region of the Menkes gene ATP7A is not altered in focal or generalized dystonia.
Annals of neurology 2003;53(2):278-9; author reply 279-80.
2003: Stiasny-Kolster K; Haeske H; Tergau F; Müller H H; Braune H J; Oertel W H
Cortical silent period is shortened in restless legs syndrome independently from circadian rhythm.
Supplements to Clinical neurophysiology 2003;56():381-9.
2003: Brandstädter D; Oertel W H
Depression in Parkinson's disease.
Advances in neurology 2003;91():371-81.
2002: Teepker Michael; Hamer Hajo M; Knake Susanne; Bandmann Oliver; Oertel Wolfgang H; Rosenow Felix
Myoclonic encephalopathy caused by chronic bismuth abuse.
Epileptic disorders : international epilepsy journal with videotape 2002;4(4):229-33.
2002: Reis Janine; Tergau Frithjof; Hamer Hajo M; Müller Hans-Helge; Knake Susanne; Fritsch Brita; Oertel Wolfgang H; Rosenow Felix
Topiramate selectively decreases intracortical excitability in human motor cortex.
Epilepsia 2002;43(10):1149-56.
2002: Suenkeler Inga H; Nowak Margarete; Misselwitz Björn; Kugler Christof; Schreiber Wolfgang; Oertel Wolfgang H; Back Tobias
Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression.
Journal of neurology 2002;249(9):1160-7.
2002: Bandmann O; Asmus F; Sibbing D; Grundmann M; Schwab S G; Müller J; Wildenauer D B; Poewe W; Gasser T; Oertel W H
Copper genes are not implicated in the pathogenesis of focal dystonia.
Neurology 2002;59(5):782-3.
2002: Stiasny Karin; Oertel Wolfgang Hermann; Trenkwalder Claudia
Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder.
Sleep medicine reviews 2002;6(4):253-65.
2002: Dodel Richard; Hampel Harald; Depboylu Candan; Lin Suizhen; Gao Feng; Schock Sabine; Jäckel Steffi; Wei Xing; Buerger Katharina; Höft Christine; Hemmer Bernhard; Möller Hans-Jürgen; Farlow Martin; Oertel Wolfgang H; Sommer Norbert; Du Yansheng
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
Annals of neurology 2002;52(2):253-6.
2002: Hagell Peter; Piccini Paola; Björklund Anders; Brundin Patrik; Rehncrona Stig; Widner Håkan; Crabb Lesley; Pavese Nicola; Oertel Wolfgang H; Quinn Niall; Brooks David J; Lindvall Olle
Dyskinesias following neural transplantation in Parkinson's disease.
Nature neuroscience 2002;5(7):627-8.
2002: Spottke E A; Volkmann J; Lorenz D; Krack P; Smala A M; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund H J; Oertel W H; Dodel R C
Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Journal of neurology 2002;249(6):759-66.
2002: Pogarell O; Gasser T; van Hilten J J; Spieker S; Pollentier S; Meier D; Oertel W H
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
Journal of neurology, neurosurgery, and psychiatry 2002;72(6):713-20.
2002: Arnold Guy; Tatsch Klaus; Kraft Eduardo; Oertel Wolfgang H; Schwarz Johannes
Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):557-62.
2002: Möller J Carsten; Stiasny Karin; Hargutt Volker; Cassel Werner; Tietze Heiko; Peter J Hermann; Krüger H-Peter; Oertel Wolfgang H
Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):474-81.
2002: Möller J C; Hamer H M; Oertel W H; Rosenow F
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).
Seizure : the journal of the British Epilepsy Association 2002;11 Suppl A():303-5.
2002: Arnold G; Schwarz J; Tatsch K; Kraft E; Wächter T; Bandmann O; Oertel W H
Steele-Richardson-Olszewski-syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):503-12.
2002: Jacobsen Marc; Cepok Sabine; Quak Elfriede; Happel Michael; Gaber Rami; Ziegler Andreas; Schock Sabine; Oertel Wolfgang H; Sommer Norbert; Hemmer Bernhard
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.
Brain : a journal of neurology 2002;125(Pt 3):538-50.
2002: Dodel R C; Du Y; Depboylu C; Kurz A; Eastwood B; Farlow M; Oertel W H; Müller U; Riemenschneider M
A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.
Neurology 2002;58(4):664.
2002: Brandstädter Dirk; Oertel Wolfgang H
Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease.
Neurology 2002;58(1):160-1.
2001: Eichhorn T E; Oertel W H
Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2001;16(6):1176-7.
2001: Cepok S; Jacobsen M; Schock S; Omer B; Jaekel S; Böddeker I; Oertel W H; Sommer N; Hemmer B
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis.
Brain : a journal of neurology 2001;124(Pt 11):2169-76.
2001: Rosenow F; Hamer H M; Knake S; Katsarou N; Fritsch B; Oertel W H; Shiratori K; Lüders H O
[Lateralizing and localizing signs and symptoms of epileptic seizures: significance and application in clinical practice]
Der Nervenarzt 2001;72(10):743-9.
2001: Du Y; Dodel R; Hampel H; Buerger K; Lin S; Eastwood B; Bales K; Gao F; Moeller H J; Oertel W; Farlow M; Paul S
Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.
Neurology 2001;57(5):801-5.
2001: Schweer D; Jacobsen M; Ziegler A; Jäkel S; Oertel W H; Sommer N; Hemmer B
No association of three polymorphisms in the alpha-2-macroglobulin and lipoprotein related receptor genes with multiple sclerosis.
Journal of neuroimmunology 2001;118(2):300-3.
2001: Earl C D; Marburger A; Sautter J; Oertel W H; Morgenstern R
The development of dopamine overflow from foetal nigral grafts in the intact rat striatum and their influence on contralateral striatal dopamine overflow.
Neurochemistry international 2001;39(2):161-7.
2001: Jacobsen M; Cepok S; Oertel W H; Sommer N; Hemmer B
New approaches to dissect degeneracy and specificity in T cell antigen recognition.
Journal of molecular medicine (Berlin, Germany) 2001;79(7):358-67.
2001: Möller J C; Hamer H M; Oertel W H; Rosenow F
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).
Seizure : the journal of the British Epilepsy Association 2001;10(4):303-6.
2001: Knake S; Rosenow F; Vescovi M; Oertel W H; Mueller H H; Wirbatz A; Katsarou N; Hamer H M;
Incidence of status epilepticus in adults in Germany: a prospective, population-based study.
Epilepsia 2001;42(6):714-8.
2001: Möller J C; Wächter T; Oertel W H
[Parkinson disease. Directed use of modern therapy]
MMW Fortschritte der Medizin 2001;143 Suppl 2():45-50.
2001: Stiasny K; Wetter T C; Winkelmann J; Brandenburg U; Penzel T; Rubin M; Hundemer H P; Oertel W H; Trenkwalder C
Long-term effects of pergolide in the treatment of restless legs syndrome.
Neurology 2001;56(10):1399-402.
2001: Dodel R C; Lohmüller F; Du Y; Eastwood B; Gocke P; Oertel W H; Gasser T
A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease.
Neurology 2001;56(7):982-3.
2001: Höglinger G U; Widmer H R; Spenger C; Meyer M; Seiler R W; Oertel W H; Sautter J
Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Experimental neurology 2001;167(1):148-57.
2001: Dodel R C; Berger K; Oertel W H
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.
PharmacoEconomics 2001;19(10):1013-38.
2001: Kupsch A; Sautter J; Götz M E; Breithaupt W; Schwarz J; Youdim M B; Riederer P; Gerlach M; Oertel W H
Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(8-9):985-1009.
2001: Oertel W H; Höglinger G U; Caraceni T; Girotti F; Eichhorn T; Spottke A E; Krieg J C; Poewe W
Depression in Parkinson's disease. An update.
Advances in neurology 2001;86():373-83.
2001: Leenders K L; Oertel W H
Parkinson's disease: clinical signs and symptoms, neural mechanisms, positron emission tomography, and therapeutic interventions.
Neural plasticity 2001;8(1-2):99-110.
2001: Tackenberg B; Hemmer B; Oertel W H; Sommer N
Immunosuppressive treatment of ocular myasthenia gravis.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2001;15(6):369-78.
2000: Muraro P A; Jacobsen M; Necker A; Nagle J W; Gaber R; Sommer N; Oertel W H; Martin R; Hemmer B
Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis.
Journal of immunological methods 2000;246(1-2):131-43.
2000: Jacobsen M; Schweer D; Ziegler A; Gaber R; Schock S; Schwinzer R; Wonigeit K; Lindert R B; Kantarci O; Schaefer-Klein J; Schipper H I; Oertel W H; Heidenreich F; Weinshenker B G; Sommer N; Hemmer B
A point mutation in PTPRC is associated with the development of multiple sclerosis.
Nature genetics 2000;26(4):495-9.
2000: Stiasny K; Möller J C; Oertel W H
Safety of pramipexole in patients with restless legs syndrome.
Neurology 2000;55(10):1589-90.
2000: Piccini P; Lindvall O; Björklund A; Brundin P; Hagell P; Ceravolo R; Oertel W; Quinn N; Samuel M; Rehncrona S; Widner H; Brooks D J
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts.
Annals of neurology 2000;48(5):689-95.
2000: Stiasny K; Oertel W H
[Restless legs syndrome. Diagnosis and therapy]
MMW Fortschritte der Medizin 2000;142(41):46-8.
2000: Möller J C; Stiasny K; Cassel W; Peter J H; Krüger H P; Oertel W H
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?]
Der Nervenarzt 2000;71(8):670-6.
2000: Sturm K; Knake S; Schomburg U; Wakat J P; Hamer H M; Fritz B; Oertel W H; Rosenow F
Autonomic seizures versus syncope in 18q- deletion syndrome: a case report.
Epilepsia 2000;41(8):1039-43.
2000: Du Y; Dodel R C; Eastwood B J; Bales K R; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans R M; Hake A; Gasser T; Oertel W H; Griffin W S; Paul S M; Farlow M R
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Neurology 2000;55(4):480-3.
2000: Sautter J; Höglinger G U; Oertel W H; Earl C D
Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.
Experimental neurology 2000;164(1):121-9.
2000: Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks D J; Marsden C D; Oertel W H; Quinn N P; Rehncrona S; Lindvall O
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain : a journal of neurology 2000;123 ( Pt 7)():1380-90.
2000: Möller J C; Oertel W H
Pramipexole in the treatment of advanced Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2000;7 Suppl 1():21-5.
2000: Benamer T S; Patterson J; Grosset D G; Booij J; de Bruin K; van Royen E; Speelman J D; Horstink M H; Sips H J; Dierckx R A; Versijpt J; Decoo D; Van Der Linden C; Hadley D M; Doder M; Lees A J; Costa D C; Gacinovic S; Oertel W H; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):503-10.
2000: Stiasny K; Röbbecke J; Schüler P; Oertel W H
Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
Sleep 2000;23(3):349-54.
2000: Hagell P; Crabb L; Pogarell O; Schrag A; Widner H; Brooks D J; Oertel W H; Quinn N P; Lindvall O
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):224-9.
2000: Pohl M; Rösler A; Sünkeler I; Braune H J; Oertel W H; Lautenbacher S
Insertion pain in needle electromyography can be reduced by simultaneous finger slapping.
Neurology 2000;54(5):1201-2.
2000: Ferger B; Teismann P; Earl C D; Kuschinsky K; Oertel W H
The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping.
Pharmacology, biochemistry, and behavior 2000;65(3):425-31.
2000: Hock C; Maddalena A; Heuser I; Naber D; Oertel W; von der Kammer H; Wienrich M; Raschig A; Deng M; Growdon J H; Nitsch R M
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;920():285-91.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Ferger B; Teismann P; Earl C D; Kuschinsky K; Oertel W H
Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(3):256-61.
1999: Künig G; Pogarell O; Möller J C; Delf M; Oertel W H
Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
Clinical neuropharmacology 1999;22(5):301-5.
1999: Knake S; Hamer H M; Schomburg U; Oertel W H; Rosenow F
Tiagabine-induced absence status in idiopathic generalized epilepsy.
Seizure : the journal of the British Epilepsy Association 1999;8(5):314-7.
1999: Fuhrmann M; Oertel W; Hegemann P
A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii.
The Plant journal : for cell and molecular biology 1999;19(3):353-61.
1999: Eggert K; Schlegel J; Oertel W; Würz C; Krieg J C; Vedder H
Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
Neuroscience letters 1999;269(3):178-82.
1999: Sommer C; Sabel M; Oertel W H; Kiessling M; Sautter J
Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease.
Brain research. Molecular brain research 1999;69(1):53-61.
1999: Pinter M M; Pogarell O; Oertel W H
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):436-41.
1999: Wetter T C; Stiasny K; Winkelmann J; Buhlinger A; Brandenburg U; Penzel T; Medori R; Rubin M; Oertel W H; Trenkwalder C
A randomized controlled study of pergolide in patients with restless legs syndrome.
Neurology 1999;52(5):944-50.
1999: Ozdemir F A; Rosenow F; Slenczka W; Kleine T O; Oertel W H
[Early summer meningoencephalitis. Extension of the endemic area to mid-Hessia]
Der Nervenarzt 1999;70(2):119-22.
1999: Möller J C; Pogarell O; Oertel W H
[The diagnosis of the parkinsonian syndrome]
Deutsche medizinische Wochenschrift (1946) 1999;124(7):193-6.
1999: Möller J C; Bandmann O; Oertel W H
[The therapy of the parkinsonian syndrome]
Deutsche medizinische Wochenschrift (1946) 1999;124(8):219-22.
1999: Schwarz J; Kraft E; Vogl T; Arnold G; Tatsch K; Oertel W H
Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism.
Neuroradiology 1999;41(2):124-8.
1999: Kraft E; Schwarz J; Trenkwalder C; Vogl T; Pfluger T; Oertel W H
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?
Archives of neurology 1999;56(2):225-8.
1999: Collado-Seidel V; Kazenwadel J; Wetter T C; Kohnen R; Winkelmann J; Selzer R; Oertel W H; Trenkwalder C
A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.
Neurology 1999;52(2):285-90.
1999: Weiner W J; Shulman L M; Oertel W H
Do we need more drugs to treat Parkinson's disease?
Advances in neurology 1999;80():481-3.
1999: Oertel W H; Bandmann O
Multiple system atrophy.
Journal of neural transmission. Supplementum 1999;56():155-64.
1998: Künig G; Pogarell O; Oertel W H
Facial pain in a case of cranial dystonia: a case report.
Cephalalgia : an international journal of headache 1998;18(10):709-11.
1998: Earl C D; Sautter J; Xie J; Kruk Z L; Kupsch A; Oertel W H
Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride.
Journal of neuroscience methods 1998;85(2):201-9.
1998: Höglinger G U; Sautter J; Meyer M; Spenger C; Seiler R W; Oertel W H; Widmer H R
Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function.
Brain research 1998;813(2):313-22.
1998: Dodel R C; Singer M; Köhne-Volland R; Szucs T; Rathay B; Scholz E; Oertel W H
The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.
PharmacoEconomics 1998;14(3):299-312.
1998: Ferger B; Spratt C; Earl C D; Teismann P; Oertel W H; Kuschinsky K
Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
Naunyn-Schmiedeberg's archives of pharmacology 1998;358(3):351-9.
1998: Wetter T C; Stiasny K; Kohnen R; Oertel W H; Trenkwalder C
Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome.
Movement disorders : official journal of the Movement Disorder Society 1998;13(5):820-4.
1998: Hartmann A; Pogarell O; Oertel W H
Secondary dystonias.
Journal of neurology 1998;245(8):511-8.
1998: Krack P; Deuschl G; Benecke R; Ceballos-Baumann A O; Marion M H; Oertel W H; Poewe W
Dose standardization of botulinum toxin.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):749-51.
1998: Schwarz S C; Schwarz J; Sautter J; Oertel W H
Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1998;120(1):95-103.
1998: Winkelmann J; Wetter T C; Stiasny K; Oertel W H; Trenkwalder C
Treatment of restless leg syndrome with pergolide--an open clinical trial.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):566-9.
1998: Baas H; Beiske A G; Ghika J; Jackson M; Oertel W H; Poewe W; Ransmayr G
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
Neurology 1998;50(5 Suppl 5):S46-53.
1998: Rösler A; Pohl M; Braune H J; Oertel W H; Gemsa D; Sprenger H
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.
Journal of the neurological sciences 1998;157(1):82-9.
1998: Dodel R C; Eggert K M; Singer M S; Eichhorn T E; Pogarell O; Oertel W H
Costs of drug treatment in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):249-54.
1998: Straube A; Ditterich J; Oertel W; Kupsch A
Electrical stimulation of the posteroventral pallidum influences internally guided saccades in Parkinson's disease.
Journal of neurology 1998;245(2):101-5.
1998: Collado-Seidel V; Kohnen R; Samtleben W; Hillebrand G F; Oertel W H; Trenkwalder C
Clinical and biochemical findings in uremic patients with and without restless legs syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(2):324-8.
1998: Scheidt C E; Rayki O; Nickel T; Heinen F; Wissel J; Poewe W; Benecke R; Arnold G; Oertel W; Dengler R; Deuschl G
[Psychosomatic aspects of idiopathic spasmodic torticollis. Results of a multicenter study]
Psychotherapie, Psychosomatik, medizinische Psychologie 1998;48(1):1-12.
1998: Kupsch A; Oertel W H
Selegiline, pregnancy, and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):175-6.
1998: Schwarz J; Tatsch K; Gasser T; Arnold G; Pogarell O; Künig G; Oertel W H
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):16-9.
1998: Poewe W; Deuschl G; Nebe A; Feifel E; Wissel J; Benecke R; Kessler K R; Ceballos-Baumann A O; Ohly A; Oertel W; Künig G
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.
Journal of neurology, neurosurgery, and psychiatry 1998;64(1):13-7.
1998: Pogarell O; Oertel W H
Neural transplantation in Parkinson's disease and its effects on rest tremor: a review of the literature.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():101-2.
1998: Sautter J; Sabel M; Sommer C; Strecker S; Weidner N; Oertel W H; Kiessling M
BDNF and TrkB expression in intrastriatal ventral mesencephalic grafts in a rat model of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(2-3):253-63.
1998: Götz M E; Breithaupt W; Sautter J; Kupsch A; Schwarz J; Oertel W H; Youdim M B; Riederer P; Gerlach M
Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset.
Journal of neural transmission. Supplementum 1998;52():271-8.
1997: Arnold G; Schwarz J; Macher C; Oertel W H
Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients - A double blind study.
Parkinsonism & related disorders 1997;3(4):191-3.
1997: Dodel R C; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter H P; Szucs T D; Oertel W H
Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
PharmacoEconomics 1997;12(6):695-706.
1997: Dodel R C; Singer M; Köhne-Volland R; Selzer R; Scholz W; Rathay B; Oertel W H
[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs]
Der Nervenarzt 1997;68(12):978-84.
1997: Kupsch A; Pogarell O; Schwarz J; Straube A; Oertel W H; Tatsch K; Linke R
Parkinson's disease and tumour in the supplementary motor area: a re-evaluation.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):811-2.
1997: Schwarz J; Tatsch K; Gasser T; Arnold G; Oertel W H
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):898-902.
1997: Sautter J; Kupsch A; Earl C D; Oertel W H
Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1997;117(1):111-9.
1997: Baas H; Beiske A G; Ghika J; Jackson M; Oertel W H; Poewe W; Ransmayr G
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
Journal of neurology, neurosurgery, and psychiatry 1997;63(4):421-8.
1997: Stiasny K; Rosenow F; Hartmann A; Hamer H M; Oertel W H
[Long-term monitoring in neurological diseases]
Der Internist 1997;38(9):830-40.
1997: Bodis-Wollner I; Bucher S F; Seelos K C; Paulus W; Reiser M; Oertel W H
Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades.
Neurology 1997;49(2):416-20.
1997: Schwarz S C; Sauer H; Oertel W H; Earl C D; Kupsch A R
Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1997;115(1):71-82.
1997: Bucher S F; Seelos K C; Oertel W H; Reiser M; Trenkwalder C
Cerebral generators involved in the pathogenesis of the restless legs syndrome.
Annals of neurology 1997;41(5):639-45.
1997: Oertel W H; Quinn N P
Parkinson's disease: drug therapy.
Baillière's clinical neurology 1997;6(1):89-108.
1997: Hellenbrand W; Seidler A; Robra B P; Vieregge P; Oertel W H; Joerg J; Nischan P; Schneider E; Ulm G
Smoking and Parkinson's disease: a case-control study in Germany.
International journal of epidemiology 1997;26(2):328-39.
1997: Tatsch K; Schwarz J; Mozley P D; Linke R; Pogarell O; Oertel W H; Fieber R S; Hahn K; Kung H F
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
European journal of nuclear medicine 1997;24(4):415-21.
1997: Smith M C; Ellgring H; Oertel W H
Sleep disturbances in Parkinson's disease patients and spouses.
Journal of the American Geriatrics Society 1997;45(2):194-9.
1997: Bucher S F; Seelos K C; Dodel R C; Reiser M; Oertel W H
Activation mapping in essential tremor with functional magnetic resonance imaging.
Annals of neurology 1997;41(1):32-40.
1997: Antonini A; Schwarz J; Oertel W H; Pogarell O; Leenders K L
Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Movement disorders : official journal of the Movement Disorder Society 1997;12(1):33-8.
1997: Scherer J; Tatsch K; Albus M; Schwarz J; Mager T; Oertel W H
D2-dopamine-receptor occupancy during treatment with haloperidol decanoate.
European archives of psychiatry and clinical neuroscience 1997;247(2):104-6.
1996: Eichhorn T E; Brunt E; Oertel W H
Ondansetron treatment of L-dopa-induced psychosis.
Neurology 1996;47(6):1608-9.
1996: Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel W H
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Brain research 1996;741(1-2):185-96.
1996: Gasser T; Müller-Myhsok B; Supala A; Zimmer E; Wieditz G; Wszolek Z K; Vieregge P; Bonifati V; Oertel W H
The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1996;61(5):518-20.
1996: Hellenbrand W; Boeing H; Robra B P; Seidler A; Vieregge P; Nischan P; Joerg J; Oertel W H; Schneider E; Ulm G
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study.
Neurology 1996;47(3):644-50.
1996: Hellenbrand W; Seidler A; Boeing H; Robra B P; Vieregge P; Nischan P; Joerg J; Oertel W H; Schneider E; Ulm G
Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study.
Neurology 1996;47(3):636-43.
1996: Bucher S F; Trenkwalder C; Oertel W H
Reflex studies and MRI in the restless legs syndrome.
Acta neurologica Scandinavica 1996;94(2):145-50.
1996: Schwarz J; Oertel W H; Tatsch K
Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonists but not L-Dopa.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1112-5.
1996: Bucher S F; Seelos K C; Dodel R C; Paulus W; Reiser M; Oertel W H
Pallidal lesions. Structural and functional magnetic resonance imaging.
Archives of neurology 1996;53(7):682-6.
1996: Trenkwalder C; Seidel V C; Gasser T; Oertel W H
Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):389-94.
1996: Gasser T; Bereznai B; Müller B; Pruszak-Seel R; Damrich R; Deuschl G; Oertel W H
Linkage studies in alcohol-responsive myoclonic dystonia.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):363-70.
1996: Dodel R C; Pepperl S; Köhne-Volland R; Szucs T; Werhahn K J; Noachtar S; Oertel W H
[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy]
Medizinische Klinik (Munich, Germany : 1983) 1996;91(7):479-85.
1996: Earl C D; Marburger A; Schönfuss D; Sautter J; Strecker S; Yang Z; Kupsch A; Oertel W H; Morgenstern R
Foetal ventral mesencephalic cell suspension grafts to the 6-hydroxydopamine-lesioned rat reduce the rate of dopamine uptake in the contralateral striatum.
Neuroscience letters 1996;210(3):185-8.
1996: Schwarz S C; Kupsch A R; Banati R; Oertel W H
Cellular immune reactions in brain transplantation: effects of graft pooling and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Glia 1996;17(2):103-20.
1996: Eichhorn T E; Gasser T; Mai N; Marquardt C; Arnold G; Schwarz J; Oertel W H
Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):289-97.
1996: Seidler A; Hellenbrand W; Robra B P; Vieregge P; Nischan P; Joerg J; Oertel W H; Ulm G; Schneider E
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.
Neurology 1996;46(5):1275-84.
1996: Earl C D; Reum T; Xie J X; Sautter J; Kupsch A; Oertel W H; Morgenstern R
Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1996;109(1):179-84.
1996: Trenkwalder C; Stiasny K; Oertel W H
[Therapy of idiopathic and uremic restless legs syndrome]
Der Nervenarzt 1996;67(4):265-76.
1996: Sautter J; Strecker S; Kupsch A; Oertel W H
Methylcellulose during cryopreservation of ventral mesencephalic tissue fragments fails to improve survival and function of cell suspension grafts.
Journal of neuroscience methods 1996;64(2):173-9.
1996: Trenkwalder C; Bucher S F; Oertel W H
Electrophysiological pattern of involuntary limb movements in the restless legs syndrome.
Muscle & nerve 1996;19(2):155-62.
1996: Gerlach M; Götz M; Dirr A; Kupsch A; Janetzky B; Oertel W; Sautter J; Schwarz J; Reichmann H; Riederer P
Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.
Neurochemistry international 1996;28(1):41-9.
1996: Schwarz J; Weis S; Kraft E; Tatsch K; Bandmann O; Mehraein P; Vogl T; Oertel W H
Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):98-101.
1996: Bucher S F; Seelos K C; Bodis-Wollner I; Paulus W; Oertel W H; Reiser M
High resolution cortical activation mapping of voluntary eye movements using functional magnetic resonance imaging.
Electroencephalography and clinical neurophysiology. Supplement 1996;47():253-8.
1996: Oertel W H; Bandmann O; Eichhorn T; Gasser T
Peripheral markers in Parkinson's disease. An overview.
Advances in neurology 1996;69():283-91.
1995: Eichhorn T E; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel W H; Poewe W
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]
Der Nervenarzt 1995;66(12):933-41.
1995: Kazenwadel J; Pollmächer T; Trenkwalder C; Oertel W H; Kohnen R; Künzel M; Krüger H P
New actigraphic assessment method for periodic leg movements (PLM).
Sleep 1995;18(8):689-97.
1995: Trenkwalder C; Schwarz J; Gebhard J; Ruland D; Trenkwalder P; Hense H W; Oertel W H
Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years.
Archives of neurology 1995;52(10):1017-22.
1995: Oertel W H; Ellgring H
Parkinson's disease--medical education and psychosocial aspects.
Patient education and counseling 1995;26(1-3):71-9.
1995: Haug B A; Kolle R U; Trenkwalder C; Oertel W H; Paulus W
Predominant affection of the blue cone pathway in Parkinson's disease.
Brain : a journal of neurology 1995;118 ( Pt 3)():771-8.
1995: Trenkwalder C; Paulus W; Krafczyk S; Hawken M; Oertel W H; Brandt T
Postural stability differentiates "lower body" from idiopathic parkinsonism.
Acta neurologica Scandinavica 1995;91(6):444-52.
1995: Seelos K C; Bucher S F; Stehling M K; Oertel W H; Reiser M
[Functional magnetic resonance tomography of the basal ganglia. Use of FLASH sequences for mapping activity with BOLD contrast ane high resolution]
Der Radiologe 1995;35(4):263-6.
1995: Bucher S F; Seelos K C; Stehling M K; Oertel W H; Reiser M
[Possibilities of technical and methodological optimization of functional magnetic resonance tomography]
Der Radiologe 1995;35(4):228-36.
1995: Oertel W H
Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
Arzneimittel-Forschung 1995;45(3A):386-9.
1995: Staude G; Wolf W; Ott M; Oertel W H; Dengler R
Tremor as a factor in prolonged reaction times of parkinsonian patients.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):153-62.
1995: Oertel W H; Dodel R C
International guide to drugs for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):121-31.
1995: Kupsch A; Gerlach M; Pupeter S C; Sautter J; Dirr A; Arnold G; Opitz W; Przuntek H; Riederer P; Oertel W H
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.
Neuroreport 1995;6(4):621-5.
1995: Bötzel K; Mayer M; Oertel W H; Paulus W
Frontal and parietal premovement slow brain potentials in Parkinson's disease and aging.
Movement disorders : official journal of the Movement Disorder Society 1995;10(1):85-91.
1995: Bucher S F; Seelos K C; Stehling M; Oertel W H; Paulus W; Reiser M
High-resolution activation mapping of basal ganglia with functional magnetic resonance imaging.
Neurology 1995;45(1):180-2.
1995: Pérez-Otaño I; Luquin M R; Oset C; Herrero M T; Kupsch A; Oertel W; Obeso J A; Del Río J
Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain.
Experimental neurology 1995;131(1):108-13.
1995: Oertel W H; Trenkwalder C; Gasser T; Schwarz J; Bucher S F; Eichhorn T; Pogarell O; Künig G; Arnold G; Bandmann O
Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".
Journal of neural transmission. Supplementum 1995;46():325-37.
1995: Kupsch A; Oertel W H; Earl C D; Sautter J
Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
Journal of neural transmission. Supplementum 1995;46():193-207.
1995: Wetter T C; Trenkwalder C; Stiasny K; Pollmächer T; Kazenwadel J; Kohnen R; Künzel M; Oertel W H
[Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study]
Wiener medizinische Wochenschrift (1946) 1995;145(17-18):525-7.
1995: Sautter J; Kupsch A; Oertel W H; Earl C D
[Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology]
Zentralblatt für Neurochirurgie 1995;56(4):161-7.
1994: Scherer J; Tatsch K; Schwarz J; Oertel W; Kirsch M C; Albus M
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics.
Biological psychiatry 1994;36(9):627-9.
1994: Schwarz J; Antonini A; Tatsch K; Kirsch C M; Oertel W H; Leenders K L
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
Nuclear medicine communications 1994;15(10):806-13.
1994: Scherer J; Tatsch K; Schwarz J; Oertel W H; Konjarczyk M; Albus M
D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.
Acta psychiatrica Scandinavica 1994;90(4):266-8.
1994: Haug B A; Trenkwalder C; Arden G B; Oertel W H; Paulus W
Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):563-70.
1994: Eichhorn T; Oertel W H
[Incidence, differential diagnosis, work capacity, mortality and cause of death in Parkinson disease]
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 1994;46(4):122-8.
1994: Antonini A; Schwarz J; Oertel W H; Beer H F; Madeja U D; Leenders K L
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Neurology 1994;44(7):1325-9.
1994: Schwarz J; Antonini A; Kraft E; Tatsch K; Vogl T; Kirsch C M; Leenders K L; Oertel W H
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
Neurology 1994;44(6):1079-82.
1994: Arnold G; Trenkwalder C; Schwarz J; Oertel W H
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):238-40.
1994: Sauer H; Oertel W H
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
Neuroscience 1994;59(2):401-15.
1994: Kupsch A; Oertel W H
Neural transplantation, trophic factors and Parkinson's disease.
Life sciences 1994;55(25-26):2083-95.
1994: Arnold G; Tatsch K; Oertel W H; Vogl T; Schwarz J; Kraft E; Kirsch C M
Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI.
Journal of neural transmission. Supplementum 1994;42():111-8.
1993: Ellgring H; Seiler S; Perleth B; Frings W; Gasser T; Oertel W
Psychosocial aspects of Parkinson's disease.
Neurology 1993;43(12 Suppl 6):S41-4.
1993: Schwarz J; Tatsch K; Arnold G; Ott M; Trenkwalder C; Kirsch C M; Oertel W H
123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
Neurology 1993;43(12 Suppl 6):S17-20.
1993: Hellenbrand W; Vieregge P; Robra B P; Nischan P; Glass J; Haagen P; Jörg J; Oertel W H; Schneider E; Ulm G
[Etiology of Parkinson disease. An epidemiologic perspective with possible implications for prevention]
Der Nervenarzt 1993;64(12):770-86.
1993: Brückner G; Brauer K; Härtig W; Wolff J R; Rickmann M J; Derouiche A; Delpech B; Girard N; Oertel W H; Reichenbach A
Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain.
Glia 1993;8(3):183-200.
1993: Oertel W H; Kupsch A
Pathogenesis and animal studies of Parkinson's disease.
Current opinion in neurology and neurosurgery 1993;6(3):323-32.
1993: Antonini A; Leenders K L; Meier D; Oertel W H; Boesiger P; Anliker M
T2 relaxation time in patients with Parkinson's disease.
Neurology 1993;43(4):697-700.
1993: Trenkwalder C; Bucher S F; Oertel W H; Proeckl D; Plendl H; Paulus W
Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome.
Electroencephalography and clinical neurophysiology 1993;89(2):95-103.
1993: Oertel W H; Schwarz J; Tatsch K; Arnold G; Gasser T; Kirsch C M
IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.
Advances in neurology 1993;60():519-24.
1993: Garner C G; Straube A; Witt T N; Gasser T; Oertel W H
Time course of distant effects of local injections of botulinum toxin.
Movement disorders : official journal of the Movement Disorder Society 1993;8(1):33-7.
1993: Oertel W H
Neurotransmitters in the cerebellum. Scientific aspects and clinical relevance.
Advances in neurology 1993;61():33-75.
1993: Arnold G; Bondy B; Bandmann O; Gasser T; Schwarz J; Trenkwalder C; Wagner M; Poewe W; Oertel W H
3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.
Journal of neural transmission. Parkinson's disease and dementia section 1993;5(2):107-16.
1992: Oertel W H; Tatsch K; Schwarz J; Kraft E; Trenkwalder C; Scherer J; Weinzierl M; Vogl T; Kirsch C M
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
Annals of neurology 1992;32(6):743-8.
1992: Gasser T; Schwarz J; Arnold G; Trenkwalder C; Oertel W H
Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.
Archives of neurology 1992;49(11):1131-4.
1992: Kupsch A; Löschmann P A; Sauer H; Arnold G; Renner P; Pufal D; Burg M; Wachtel H; ten Bruggencate G; Oertel W H
Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.
Brain research 1992;592(1-2):74-83.
1992: Fritschy J M; Benke D; Mertens S; Oertel W H; Bachi T; Möhler H
Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):6726-30.
1992: Pérez-Otaño I; Oset C; Trinidad Herrero M; Luquin M R; Kupsch A; Oertel W; Obeso J A; Del Río J
Neurotoxic effect of prenatal exposure to MPTP on the dopaminergic systems of the marmoset brain.
European journal of pharmacology 1992;217(2-3):211-3.
1992: Wüllner U; Kupsch A; Arnold G; Renner P; Scheid C; Scheid R; Oertel W; Klockgether T
The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets.
Neuropharmacology 1992;31(7):713-5.
1992: Staude G; Wolf W; Wierzbicka M M; Oertel W; Dengler R
[The dependence of rapid voluntary contractions on the tremor phase in parkinsonism]
EEG-EMG Zeitschrift für Elektroenzephalographie, Elektromyographie und verwandte Gebiete 1992;23(2):108-13.
1992: Schwarz J; Tatsch K; Arnold G; Gasser T; Trenkwalder C; Kirsch C M; Oertel W H
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism.
Neurology 1992;42(3 Pt 1):556-61.
1992: Sirinathsinghji D J; Kupsch A; Mayer E; Zivin M; Pufal D; Oertel W H
Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Brain research. Molecular brain research 1992;12(1-3):267-74.
1992: Schwarz J; Trenkwalder C; Gasser T; Arnold G; Oertel W H
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trial.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(1):35-41.
1992: Schwarz J; Tatsch K; Vogl T; Kirsch C M; Trenkwalder C; Arnold G; Gasser T; Oertel W H
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):58-61.
1992: Sauer H; Frodl E M; Kupsch A; ten Bruggencate G; Oertel W H
Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1992;90(1):54-62.
1991: Gasser T; Trenkwalder C; Meitinger T; Witt T N; Murken J; Oertel W H
[Neurogenetics--the challenge for neurology. 1. Neurogenetic diseases]
Der Nervenarzt 1991;62(10):590-608.
1991: Tatsch K; Schwarz J; Oertel W H; Kirsch C M
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.
Nuclear medicine communications 1991;12(8):699-707.
1991: Kupsch A; Sauer H; Oertel W H
[Transplantation of dopamine producing nerve cells: a new therapy in idiopathic Parkinson syndrome?]
Der Nervenarzt 1991;62(2):80-91.
1990: Ceballos-Baumann A O; Gasser T; Dengler R; Oertel W H
[Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients]
Der Nervenarzt 1990;61(10):604-10.
1990: Ellgring H; Seiler S; Nagel U; Perleth B; Gasser T; Oertel W H
Psychosocial problems of Parkinson patients: approaches to assessment and treatment.
Advances in neurology 1990;53():349-53.
1989: Ackermann H; Ziegler W; Oertel W H
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):805-7.
1989: Oertel W H; Gnahn H; Struppler A
[Parkinson syndrome. II: New aspects of therapy]
Medizinische Klinik (Munich, Germany : 1983) 1989;84(6):307-13.
1989: Granholm A C; Eriksdotter-Nilsson M; Strömberg I; Stieg P; Seiger A; Bygdeman M; Geffard M; Oertel W; Dahl D; Olson L
Morphological and electrophysiological studies of human hippocampal transplants in the anterior eye chamber of athymic nude rats.
Experimental neurology 1989;104(2):162-71.
1989: Oertel W H; Gnahn H; Struppler A
[Parkinson syndrome. I: New aspects in research and diagnosis]
Medizinische Klinik (Munich, Germany : 1983) 1989;84(5):258-61.
1989: Poewe W; Kleedorfer B; Wagner M; Benke T; Gasser T; Oertel W
Side-effects of subcutaneous apomorphine in Parkinson's disease.
Lancet 1989;1(8646):1084-5.
1988: Meister B; Hökfelt T; Geffard M; Oertel W
Glutamic acid decarboxylase- and gamma-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus.
Neuroendocrinology 1988;48(5):516-26.
1988: Temlett J A; Chong P N; Oertel W H; Jenner P; Marsden C D
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset.
European journal of pharmacology 1988;156(2):197-206.
1988: Buchner E; Bader R; Buchner S; Cox J; Emson P C; Flory E; Heizmann C W; Hemm S; Hofbauer A; Oertel W H
Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system.
Cell and tissue research 1988;253(2):357-70.
1988: Poewe W; Kleedorfer B; Gerstenbrand F; Oertel W
Subcutaneous apomorphine in Parkinson's disease.
Lancet 1988;1(8591):943.
1988: Massari V J; Chan J; Chronwall B M; O'Donohue T L; Oertel W H; Pickel V M
Neuropeptide Y in the rat nucleus accumbens: ultrastructural localization in aspiny neurons receiving synaptic input from GABAergic terminals.
Journal of neuroscience research 1988;19(2):171-86.
1988: Fine A; Hunt S P; Oertel W H; Nomoto M; Chong P N; Bond A; Waters C; Temlett J A; Annett L; Dunnett S
Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Progress in brain research 1988;78():479-89.
1987: Blessing W W; Hedger S C; Oertel W H
Vestibulospinal pathway in rabbit includes GABA-synthesizing neurons.
Neuroscience letters 1987;80(2):158-62.
1987: Milner T A; Pickel V M; Chan J; Massari V J; Oertel W H; Park D H; Joh T H; Reis D J
Phenylethanolamine N-methyltransferase-containing neurons in the rostral ventrolateral medulla. II. Synaptic relationships with GABAergic terminals.
Brain research 1987;411(1):46-57.
1987: Millhorn D E; Hökfelt T; Seroogy K; Oertel W; Verhofstad A A; Wu J Y
Immunohistochemical evidence for colocalization of gamma-aminobutyric acid and serotonin in neurons of the ventral medulla oblongata projecting to the spinal cord.
Brain research 1987;410(1):179-85.
1987: Kawai Y; Emson P C; Hillyard C J; Girgis S; MacIntyre I; Oertel W H; Tohyama M
Immunohistochemical evidence for the coexistence of calcitonin gene-related peptide and glutamate decarboxylase-like immunoreactivities in the Purkinje cells of the rat cerebellum.
Brain research 1987;409(2):371-3.
1987: Legay F; Weise V K; Oertel W H; Tappaz M L
Taurine biosynthesis in rat brain: a new specific and sensitive microassay of cysteine sulfinate decarboxylase (CSDI) activity through selective immunotrapping and its use for distribution studies.
Journal of neurochemistry 1987;48(2):345-51.
1987: Pöppel E; Stoerig P; Logothetis N; Fries W; Boergen K P; Oertel W; Zihl J
Plasticity and rigidity in the representation of the human visual field.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1987;68(2):445-8.
1987: Eriksdotter-Nilsson M; Meister B; Hökfelt T; Elde R; Fahrenkrug J; Frey P; Oertel W; Rehfeld J F; Terenius L; Olson L
Glutamic acid decarboxylase- and peptide-immunoreactive neurons in cortex cerebri following development in isolation: evidence of homotypic and disturbed patterns in intraocular grafts.
Synapse (New York, N.Y.) 1987;1(6):539-51.
1986: Melander T; Hökfelt T; Rökaeus A; Cuello A C; Oertel W H; Verhofstad A; Goldstein M
Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1986;6(12):3640-54.
1986: Ribak C E; Hunt C A; Bakay R A; Oertel W H
A decrease in the number of GABAergic somata is associated with the preferential loss of GABAergic terminals at epileptic foci.
Brain research 1986;363(1):78-90.
1986: Braak E; Olbrich H G; Braak H; Wieser H G; Oertel W H
Glutamic acid decarboxylase immunoreactivity in sector CA1 of the human Ammon's horn.
Anatomy and embryology 1986;175(1):15-23.
1986: Basbaum A I; Glazer E J; Oertel W
Immunoreactive glutamic acid decarboxylase in the trigeminal nucleus caudalis of the cat: a light- and electron-microscopic analysis.
Somatosensory research 1986;4(1):77-94.
1986: Flügge G; Oertel W H; Wuttke W
Evidence for estrogen-receptive GABAergic neurons in the preoptic/anterior hypothalamic area of the rat brain.
Neuroendocrinology 1986;43(1):1-5.
1986: Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel W H; Goldstein M
Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1986;64(1):169-92.
1985: Roberts R C; Ribak C E; Oertel W H
Increased numbers of GABAergic neurons occur in the inferior colliculus of an audiogenic model of genetic epilepsy.
Brain research 1985;361(1-2):324-38.
1985: Peterson G M; Ribak C E; Oertel W H
A regional increase in the number of hippocampal GABAergic neurons and terminals in the seizure-sensitive gerbil.
Brain research 1985;340(2):384-9.
1985: Walker L C; Kitt C A; Struble R G; Schmechel D E; Oertel W H; Cork L C; Price D L
Glutamic acid decarboxylase-like immunoreactive neurites in senile plaques.
Neuroscience letters 1985;59(2):165-9.
1985: Kultas-Ilinsky K; Ribak C E; Peterson G M; Oertel W H
A description of the GABAergic neurons and axon terminals in the motor nuclei of the cat thalamus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1985;5(5):1346-69.
1984: Takeda N; Inagaki S; Shiosaka S; Taguchi Y; Oertel W H; Tohyama M; Watanabe T; Wada H
Immunohistochemical evidence for the coexistence of histidine decarboxylase-like and glutamate decarboxylase-like immunoreactivities in nerve cells of the magnocellular nucleus of the posterior hypothalamus of rats.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(23):7647-50.
1984: Blessing W W; Oertel W H; Willoughby J O
Glutamic acid decarboxylase immunoreactivity is present in perikarya of neurons in nucleus tractus solitarius of rat.
Brain research 1984;322(2):346-50.
1984: Mugnaini E; Wouterlood F G; Dahl A L; Oertel W H
Immunocytochemical identification of GABAergic neurons in the main olfactory bulb of the rat.
Archives italiennes de biologie 1984;122(2):83-113.
1984: Wolff J R; Böttcher H; Zetzsche T; Oertel W H; Chronwall B M
Development of GABAergic neurons in rat visual cortex as identified by glutamate decarboxylase-like immunoreactivity.
Neuroscience letters 1984;47(3):207-12.
1984: Oertel W H; Mugnaini E
Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems.
Neuroscience letters 1984;47(3):233-8.
1984: Mugnaini E; Oertel W H; Wouterlood F F
Immunocytochemical localization of GABA neurons and dopamine neurons in the rat main and accessory olfactory bulbs.
Neuroscience letters 1984;47(3):221-6.
1984: Frotscher M; Léránth C; Lübbers K; Oertel W H
Commissural afferents innervate glutamate decarboxylase immunoreactive non-pyramidal neurons in the guinea pig hippocampus.
Neuroscience letters 1984;46(2):137-43.
1984: Jirikowski G; Reisert I; Pilgrim C; Oertel W H
Coexistence of glutamate decarboxylase and somatostatin immunoreactivity in cultured hippocampal neurons of the rat.
Neuroscience letters 1984;46(1):35-9.
1984: Oertel W H; Nitsch C; Mugnaini E
Immunocytochemical demonstration of the GABA-ergic neurons in rat globus pallidus and nucleus entopeduncularis and their GABA-ergic innervation.
Advances in neurology 1984;40():91-8.
1984: Elde R; Seybold V; Sorenson R L; Cummings S; Holets V; Onstott D; Sasek C; Schmechel D E; Oertel W H
Peptidergic regulation in neuroendocrine and autonomic systems.
Peptides 1984;5 Suppl 1():101-7.
1983: Wagner G P; Oertel W H; Wolff J R
Entorhinal lesions result in shrinkage of the outer molecular layer of rat dentate gyrus leading subsequently to an apparent increase of glutamate decarboxylase and cytochrome oxidase activities.
Neuroscience letters 1983;39(3):255-60.
1983: Tappaz M L; Wassef M; Oertel W H; Paut L; Pujol J F
Light- and electron-microscopic immunocytochemistry of glutamic acid decarboxylase (GAD) in the basal hypothalamus: morphological evidence for neuroendocrine gamma-aminobutyrate (GABA).
Neuroscience 1983;9(2):271-87.
1983: Oertel W H; Graybiel A M; Mugnaini E; Elde R P; Schmechel D E; Kopin I J
Coexistence of glutamic acid decarboxylase- and somatostatin-like immunoreactivity in neurons of the feline nucleus reticularis thalami.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1983;3(6):1322-32.
1983: Kirino T; Brightman M W; Oertel W H; Schmechel D E; Marangos P J
Neuron-specific enolase as an index of neuronal regeneration and reinnervation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1983;3(5):915-23.
1983: Neale E A; Oertel W H; Bowers L M; Weise V K
Glutamate decarboxylase immunoreactivity and gamma-[3H] aminobutyric acid accumulation within the same neurons in dissociated cell cultures of cerebral cortex.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1983;3(2):376-82.
1983: Oertel W H; Riethmüller G; Mugnaini E; Schmechel D E; Weindl A; Gramsch C; Herz A
Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleus.
Life sciences 1983;33 Suppl 1():73-6.
1982: Oertel W H; Tappaz M L; Berod A; Mugnaini E
Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta.
Brain research bulletin 1982;9(1-6):463-74.
1982: Reisert I; Jirikowski G; Pilgrim C; Oertel W; Marangos P J
The development of immunoreactivity for neuron-specific enolase of preoptic and septal neurons in dissociated cultures.
Neuroscience 1982;7(5):1317-22.
1982: Meyer D K; Beinfeld M C; Oertel W H; Brownstein M J
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen.
Science (New York, N.Y.) 1982;215(4529):187-8.
1982: Oertel W H; Mugnaini E; Tappaz M L; Weise V K; Dahl A L; Schmechel D E; Kopin I J
Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(2):675-9.
1982: Tappaz M L; Oertel W H; Wassef M; Mugnaini E
Central GABAergic neuroendocrine regulations: pharmacological and morphological evidence.
Progress in brain research 1982;55():77-96.
1981: Handelmann G; Meyer D K; Beinfeld M C; Oertel W H
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study.
Brain research 1981;224(1):180-4.
1981: Oertel W H; Schmechel D E; Brownstein M J; Tappaz M L; Ransom D H; Kopin I J
Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1981;29(8):977-80.
1981: Gallager D W; Mallorga P; Oertel W; Henneberry R; Tallman J
[3H]Diazepam binding in mammalian central nervous system: a pharmacological characterization.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1981;1(2):218-25.
1981: Tappaz M L; Aguera M; Belin M F; Oertel W H; Schmechel D E; Kopin I J; Pujol J F
GABA markers in the hypothalamic median eminence.
Advances in biochemical psychopharmacology 1981;26():229-36.
1981: Oertel W H; Schmechel D E; Weise V K; Ransom D H; Tappaz M L; Krutzsch H C; Kopin I J
Comparison of cysteine sulphinic acid decarboxylase isoenzymes and glutamic acid decarboxylase in rat liver and brain.
Neuroscience 1981;6(12):2701-14.
1981: Oertel W H; Schmechel D E; Tappaz M L; Kopin I J
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex.
Neuroscience 1981;6(12):2689-700.
1981: Oertel W H; Schmechel D E; Mugnaini E; Tappaz M L; Kopin I J
Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum.
Neuroscience 1981;6(12):2715-35.
1981: Barker J L; MacDonald J F; Mathers D A; McBurney R N; Oertel W
GABA receptor functions in cultured mouse spinal neurons.
Advances in biochemical psychopharmacology 1981;29():281-93.
1980: Oertel W H; Schmechel D E; Daly J W; Tappaz M L; Kopin I J
Localization of glutamate decarboxylase on line-immunoelectrophoresis and two-dimensional electrophoresis by use of the radioactive suicide substrate [2-3H]-gamma-acetylenic GABA.
Life sciences 1980;27(22):2133-41.
1980: Meyer D K; Oertel W H; Brownstein M J
Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat.
Brain research 1980;200(1):165-8.
1977: Klinke R; Oertel W
Evidence that GABA is not the afferent transmitter in the cochlea.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1977;28(3-4):311-4.
1973: Galley N; Klinke R; Oertel W; Pause M; Storch W H
The effect of intracochlearly administered acetylcholine-blocking agents on the efferent synapses of the cochlea.
Brain research 1973;64():55-63.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Wolfgang Oertel

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Geographic Areas

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Wolfgang Oertel (preview)

All Publications